{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:48:05Z","timestamp":1793972885516,"version":"4.8.0"},"reference-count":430,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82403230"],"award-info":[{"award-number":["No.82403230"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["No.2024M763714"],"award-info":[{"award-number":["No.2024M763714"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Postdoctoral Fellowship Program of CPSF","award":["GZC20233156"],"award-info":[{"award-number":["GZC20233156"]}]},{"name":"Science and Technology Program Foundation of Changsha City","award":["kq2403019"],"award-info":[{"award-number":["kq2403019"]}]},{"name":"Special Funding for the Construction of Innovative Province in Hunan","award":["2022SK2041"],"award-info":[{"award-number":["2022SK2041"]}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province of China","doi-asserted-by":"crossref","award":["2024JJ6664"],"award-info":[{"award-number":["2024JJ6664"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Medical Awards Foundation","award":["YXJL-2024-1352-0612"],"award-info":[{"award-number":["YXJL-2024-1352-0612"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"DOI":"10.1186\/s13045-026-01831-5","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T20:43:14Z","timestamp":1784407394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Copper homeostasis and cuproptosis rewire the tumor microenvironment: mechanisms, immune modulation, and therapeutic opportunities"],"prefix":"10.1186","volume":"19","author":[{"given":"Guoqing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"issue":"5","key":"1831_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/cac2.70001","volume":"45","author":"K Lu","year":"2025","unstructured":"Lu K, Wijaya CS, Yao Q, Jin H, Feng L. Cuproplasia and cuproptosis, two sides of the coin. Cancer Commun (Lond). 2025;45(5):505\u201324.","journal-title":"Cancer Commun (Lond)"},{"key":"1831_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2025.02.011","volume":"112","author":"K Bhatnagar","year":"2025","unstructured":"Bhatnagar K, Raju S, Patki N, Motiani RK, Chaudhary S. Targeting mineral metabolism in cancer: insights into signaling pathways and therapeutic strategies. Semin Cancer Biol. 2025;112:1\u201319.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"1831_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7(1):378.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1831_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1152\/physrev.00011.2024","volume":"105","author":"S Lutsenko","year":"2025","unstructured":"Lutsenko S, Roy S, Tsvetkov P. Mammalian copper homeostasis: physiological roles and molecular mechanisms. Physiol Rev. 2025;105(1):441\u201391.","journal-title":"Physiol Rev"},{"issue":"1","key":"1831_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12964-024-01726-3","volume":"22","author":"TTT Vo","year":"2024","unstructured":"Vo TTT, Peng TY, Nguyen TH, Bui TNH, Wang CS, Lee WJ, et al. The crosstalk between copper-induced oxidative stress and cuproptosis: a novel potential anticancer paradigm. Cell Commun Signal. 2024;22(1):353.","journal-title":"Cell Commun Signal"},{"issue":"6586","key":"1831_CR6","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254\u201361.","journal-title":"Science"},{"issue":"2","key":"1831_CR7","doi-asserted-by":"publisher","first-page":"118893","DOI":"10.1016\/j.bbamcr.2020.118893","volume":"1868","author":"VC Shanbhag","year":"2021","unstructured":"Shanbhag VC, Gudekar N, Jasmer K, Papageorgiou C, Singh K, Petris MJ. Copper metabolism as a unique vulnerability in cancer. Biochim Biophys Acta Mol Cell Res. 2021;1868(2):118893.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"1831_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.218192","volume":"639","author":"F Duan","year":"2025","unstructured":"Duan F, Zhang C, Wu Z, Zhuang L, Zou Y, Wang X, et al. Copper orchestrates triple-negative breast cancer progression via the STEAP3-dependent CDK16-JAK1 activation. Cancer Lett. 2025;639:218192.","journal-title":"Cancer Lett"},{"issue":"40","key":"1831_CR9","doi-asserted-by":"publisher","first-page":"e17795","DOI":"10.1002\/advs.202417795","volume":"12","author":"X Lin","year":"2025","unstructured":"Lin X, Chen W, Li B, Zhao Z, Yu Z, Zhao XY, et al. Targeting intratumoral copper inhibits tumor progression via p62-mediated EZH2 degradation and potentiates anti-PD-1 immunotherapy in oral squamous cell carcinoma. Adv Sci (Weinh). 2025;12(40):e17795.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"1831_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","volume":"22","author":"J Xie","year":"2023","unstructured":"Xie J, Yang Y, Gao Y, He J. Cuproptosis: mechanisms and links with cancers. Mol Cancer. 2023;22(1):46.","journal-title":"Mol Cancer"},{"issue":"1","key":"1831_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40164-024-00539-x","volume":"13","author":"Y Yin","year":"2024","unstructured":"Yin Y, Feng W, Chen J, Chen X, Wang G, Wang S, et al. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside. Exp Hematol Oncol. 2024;13(1):72.","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"1831_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"issue":"1","key":"1831_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12943-023-01752-8","volume":"22","author":"Y Qin","year":"2023","unstructured":"Qin Y, Liu Y, Xiang X, Long X, Chen Z, Huang X, et al. Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis. Mol Cancer. 2023;22(1):59.","journal-title":"Mol Cancer"},{"issue":"7960","key":"1831_CR14","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41586-023-06017-4","volume":"617","author":"S Solier","year":"2023","unstructured":"Solier S, M\u00fcller S, Ca\u00f1eque T, Versini A, Mansart A, Sindikubwabo F, et al. A druggable copper-signalling pathway that drives inflammation. Nature. 2023;617(7960):386\u201394.","journal-title":"Nature"},{"key":"1831_CR15","doi-asserted-by":"publisher","first-page":"0039","DOI":"10.34133\/bmr.0039","volume":"28","author":"Y Luo","year":"2024","unstructured":"Luo Y, Luo X, Ru Y, Zhou X, Liu D, Huang Q, et al. Copper(II)-based nano-regulator correlates cuproptosis burst and sequential immunogenic cell death for synergistic cancer immunotherapy. Biomater Res. 2024;28:0039.","journal-title":"Biomater Res"},{"key":"1831_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.clnu.2025.03.023","volume":"48","author":"Y Fu","year":"2025","unstructured":"Fu Y, Hou L, Han K, Zhao C, Hu H, Yin S. The physiological role of copper: dietary sources, metabolic regulation, and safety concerns. Clin Nutr. 2025;48:161\u201379.","journal-title":"Clin Nutr"},{"issue":"10","key":"1831_CR17","doi-asserted-by":"publisher","first-page":"e724","DOI":"10.1002\/mco2.724","volume":"5","author":"Y Yang","year":"2020","unstructured":"Yang Y, Wu J, Wang L, Ji G, Dang Y. Copper homeostasis and cuproptosis in health and disease. MedComm. 2020;5(10):e724.","journal-title":"MedComm"},{"issue":"3","key":"1831_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1053\/gast.2000.17834","volume":"119","author":"H Roelofsen","year":"2000","unstructured":"Roelofsen H, Wolters H, Van Luyn MJ, Miura N, Kuipers F, Vonk RJ. Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion. Gastroenterology. 2000;119(3):782\u201393.","journal-title":"Gastroenterology"},{"key":"1831_CR19","doi-asserted-by":"publisher","first-page":"127459","DOI":"10.1016\/j.jtemb.2024.127459","volume":"84","author":"V Einhorn","year":"2024","unstructured":"Einhorn V, Haase H, Maares M. Interaction and competition for intestinal absorption by zinc, iron, copper, and manganese at the intestinal mucus layer. J Trace Elem Med Biol. 2024;84:127459.","journal-title":"J Trace Elem Med Biol"},{"issue":"1","key":"1831_CR20","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1038\/s41467-018-06817-7","volume":"9","author":"W Oosterheert","year":"2018","unstructured":"Oosterheert W, van Bezouwen LS, Rodenburg RNP, Granneman J, F\u00f6rster F, Mattevi A, et al. Cryo-EM structures of human STEAP4 reveal mechanism of iron(III) reduction. Nat Commun. 2018;9(1):4337.","journal-title":"Nat Commun"},{"issue":"2","key":"1831_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.biocel.2009.11.007","volume":"42","author":"S La Fontaine","year":"2010","unstructured":"La Fontaine S, Ackland ML, Mercer JF. Mammalian copper-transporting P-type ATPases, ATP7A and ATP7B: emerging roles. Int J Biochem Cell Biol. 2010;42(2):206\u20139.","journal-title":"Int J Biochem Cell Biol"},{"issue":"8","key":"1831_CR22","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, Kang R, Klionsky DJ, Tang D, Liu J, Chen X. Copper metabolism in cell death and autophagy. Autophagy. 2023;19(8):2175\u201395.","journal-title":"Autophagy"},{"issue":"52","key":"1831_CR23","doi-asserted-by":"publisher","first-page":"36952","DOI":"10.1074\/jbc.274.52.36952","volume":"274","author":"PJ Schmidt","year":"1999","unstructured":"Schmidt PJ, Ramos-Gomez M, Culotta VC. A gain of superoxide dismutase (SOD) activity obtained with CCS, the copper metallochaperone for SOD1. J Biol Chem. 1999;274(52):36952\u20136.","journal-title":"J Biol Chem"},{"key":"1831_CR24","doi-asserted-by":"publisher","first-page":"102990","DOI":"10.1016\/j.redox.2023.102990","volume":"69","author":"D Huang","year":"2024","unstructured":"Huang D, Chen L, Ji Q, Xiang Y, Zhou Q, Chen K, et al. Lead aggravates Alzheimer\u2019s disease pathology via mitochondrial copper accumulation regulated by COX17. Redox Biol. 2024;69:102990.","journal-title":"Redox Biol"},{"issue":"19","key":"1831_CR25","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.1021\/bi025664v","volume":"41","author":"P Palumaa","year":"2002","unstructured":"Palumaa P, Eriste E, Njunkova O, Pokras L, J\u00f6rnvall H, Sillard R. Brain-specific metallothionein-3 has higher metal-binding capacity than ubiquitous metallothioneins and binds metals noncooperatively. Biochemistry. 2002;41(19):6158\u201363.","journal-title":"Biochemistry"},{"issue":"5","key":"1831_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4103\/2319-4170.132888","volume":"37","author":"M Baharvand","year":"2014","unstructured":"Baharvand M, Manifar S, Akkafan R, Mortazavi H, Sabour S. Serum levels of ferritin, copper, and zinc in patients with oral cancer. Biomed J. 2014;37(5):331\u20136.","journal-title":"Biomed J"},{"issue":"3","key":"1831_CR27","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.4143\/crt.2015.282","volume":"48","author":"MR Lener","year":"2016","unstructured":"Lener MR, Scott RJ, Wiechowska-Koz\u0142owska A, Serrano-Fern\u00e1ndez P, Baszuk P, Jaworska-Bieniek K, et al. Serum concentrations of selenium and copper in patients diagnosed with pancreatic cancer. Cancer Res Treat. 2016;48(3):1056\u201364.","journal-title":"Cancer Res Treat"},{"issue":"8","key":"1831_CR28","doi-asserted-by":"publisher","first-page":"e0237370","DOI":"10.1371\/journal.pone.0237370","volume":"15","author":"Y Tamai","year":"2020","unstructured":"Tamai Y, Iwasa M, Eguchi A, Shigefuku R, Sugimoto K, Hasegawa H, et al. Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma. PLoS ONE. 2020;15(8):e0237370.","journal-title":"PLoS ONE"},{"issue":"2","key":"1831_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-24-0187","volume":"15","author":"ME Bischoff","year":"2025","unstructured":"Bischoff ME, Shamsaei B, Yang J, Secic D, Vemuri B, Reisz JA, et al. Copper drives remodeling of metabolic state and progression of clear cell renal cell carcinoma. Cancer Discov. 2025;15(2):401\u201326.","journal-title":"Cancer Discov"},{"issue":"2","key":"1831_CR30","first-page":"981","volume":"46","author":"U Carpentieri","year":"1986","unstructured":"Carpentieri U, Myers J, Thorpe L, Daeschner CW 3rd, Haggard ME. Copper, zinc, and iron in normal and leukemic lymphocytes from children. Cancer Res. 1986;46(2):981\u20134.","journal-title":"Cancer Res"},{"issue":"1","key":"1831_CR31","doi-asserted-by":"publisher","first-page":"7311","DOI":"10.1038\/s41467-021-27559-z","volume":"12","author":"D Ramchandani","year":"2021","unstructured":"Ramchandani D, Berisa M, Tavarez DA, Li Z, Miele M, Bai Y, et al. Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis. Nat Commun. 2021;12(1):7311.","journal-title":"Nat Commun"},{"issue":"3","key":"1831_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41587-020-0707-9","volume":"39","author":"L Cui","year":"2021","unstructured":"Cui L, Gouw AM, LaGory EL, Guo S, Attarwala N, Tang Y, et al. Mitochondrial copper depletion suppresses triple-negative breast cancer in mice. Nat Biotechnol. 2021;39(3):357\u201367.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1831_CR33","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1186\/s12951-025-03902-0","volume":"23","author":"J Wang","year":"2025","unstructured":"Wang J, Zhao M, Zhang J, Zhang X, Zhu H, Wang C, et al. Protective effects of biomimetic Cu-Zn-MOF against DOX-induced cardiotoxicity through inhibiting oxidative stress and ferroptosis. J Nanobiotechnol. 2025;23(1):768.","journal-title":"J Nanobiotechnol"},{"key":"1831_CR34","doi-asserted-by":"publisher","first-page":"14780","DOI":"10.1038\/srep14780","volume":"5","author":"GF Chen","year":"2015","unstructured":"Chen GF, Sudhahar V, Youn SW, Das A, Cho J, Kamiya T, et al. Copper transport protein antioxidant-1 promotes inflammatory neovascularization via chaperone and transcription factor function. Sci Rep. 2015;5:14780.","journal-title":"Sci Rep"},{"issue":"7501","key":"1831_CR35","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature13180","volume":"509","author":"DC Brady","year":"2014","unstructured":"Brady DC, Crowe MS, Turski ML, Hobbs GA, Yao X, Chaikuad A, et al. Copper is required for oncogenic BRAF signalling and tumorigenesis. Nature. 2014;509(7501):492\u20136.","journal-title":"Nature"},{"issue":"1","key":"1831_CR36","doi-asserted-by":"publisher","first-page":"130876","DOI":"10.1016\/j.bbagen.2025.130876","volume":"1870","author":"Y Ma","year":"2026","unstructured":"Ma Y, Liu L, Duan J, Wang X. Copper transporter 1 contributes to the progression of cholangiocarcinoma. Biochim Biophys Acta Gen Subj. 2026;1870(1):130876.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"1831_CR37","doi-asserted-by":"publisher","first-page":"215793","DOI":"10.1016\/j.canlet.2022.215793","volume":"543","author":"P Zhang","year":"2022","unstructured":"Zhang P, Li B, Chen Q, Wang H, Feng Q. Glucose restriction induces ROS-AMPK-mediated CTR1 expression and increases cisplatin efficiency in NSCLC. Cancer Lett. 2022;543:215793.","journal-title":"Cancer Lett"},{"issue":"3","key":"1831_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/vco.12903","volume":"21","author":"PL Rivera","year":"2023","unstructured":"Rivera PL, Li WT, Bhogal S, Mandell JB, Belayneh R, Hankins ML, et al. Antioxidant 1 copper chaperone gene expression and copper levels in dog osteosarcoma patients. Vet Comp Oncol. 2023;21(3):559\u201364.","journal-title":"Vet Comp Oncol"},{"issue":"3","key":"1831_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12282-019-01044-4","volume":"27","author":"S Blockhuys","year":"2020","unstructured":"Blockhuys S, Brady DC, Wittung-Stafshede P. Evaluation of copper chaperone ATOX1 as prognostic biomarker in breast cancer. Breast Cancer. 2020;27(3):505\u20139.","journal-title":"Breast Cancer"},{"issue":"21","key":"1831_CR40","first-page":"7038","volume":"63","author":"C Suzuki","year":"2003","unstructured":"Suzuki C, Daigo Y, Kikuchi T, Katagiri T, Nakamura Y. Identification of COX17 as a therapeutic target for non-small cell lung cancer. Cancer Res. 2003;63(21):7038\u201341.","journal-title":"Cancer Res"},{"key":"1831_CR41","doi-asserted-by":"publisher","first-page":"117955492312192","DOI":"10.1177\/11795549231219239","volume":"18","author":"Y Li","year":"2024","unstructured":"Li Y, Du W, Yang R, Wei X, Li H, Zhang X. Copper chaperone for superoxide dismutase subtypes as a prognostic marker in luminal B breast cancer. Clin Med Insights Oncol. 2024;18:11795549231219240.","journal-title":"Clin Med Insights Oncol"},{"issue":"6","key":"1831_CR42","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/sj.bjc.6603028","volume":"94","author":"G Weinlich","year":"2006","unstructured":"Weinlich G, Eisendle K, Hassler E, Baltaci M, Fritsch PO, Zelger B. Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients. Br J Cancer. 2006;94(6):835\u201341.","journal-title":"Br J Cancer"},{"issue":"12","key":"1831_CR43","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.humpath.2009.01.026","volume":"40","author":"KJ Schmitz","year":"2009","unstructured":"Schmitz KJ, Lang H, Kaiser G, Wohlschlaeger J, Sotiropoulos GC, Baba HA, et al. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors). Hum Pathol. 2009;40(12):1706\u201314.","journal-title":"Hum Pathol"},{"key":"1831_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1479-5876-10-21","volume":"10","author":"ZH Li","year":"2012","unstructured":"Li ZH, Qiu MZ, Zeng ZL, Luo HY, Wu WJ, Wang F, et al. Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC). J Transl Med. 2012;10:21.","journal-title":"J Transl Med"},{"key":"1831_CR45","doi-asserted-by":"publisher","first-page":"110401","DOI":"10.1016\/j.biopha.2020.110401","volume":"129","author":"D Lukanovi\u0107","year":"2020","unstructured":"Lukanovi\u0107 D, Herzog M, Kobal B, \u010cerne K. The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer. Biomed Pharmacother. 2020;129:110401.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1831_CR46","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1073\/pnas.1910722117","volume":"117","author":"S Blockhuys","year":"2020","unstructured":"Blockhuys S, Zhang X, Wittung-Stafshede P. Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration. Proc Natl Acad Sci U S A. 2020;117(4):2014\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1831_CR47","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1007\/s12011-024-04440-w","volume":"203","author":"R Squitti","year":"2025","unstructured":"Squitti R, Tondolo V, Pal A, Rizzo G, Arijit S, Mehboob H, et al. Copper dysmetabolism is connected to epithelial-mesenchymal transition: a pilot study in colorectal cancer patients. Biol Trace Elem Res. 2025;203(7):3604\u201317.","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"1831_CR48","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13046-025-03486-5","volume":"44","author":"J Suwara","year":"2025","unstructured":"Suwara J, Hartman ML. Balancing between cuproplasia and copper-dependent cell death: molecular basis and clinical implications of ATOX1 in cancer. J Exp Clin Cancer Res. 2025;44(1):222.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"1831_CR49","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","volume":"15","author":"P Tsvetkov","year":"2019","unstructured":"Tsvetkov P, Detappe A, Cai K, Keys HR, Brune Z, Ying W, et al. Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat Chem Biol. 2019;15(7):681\u20139.","journal-title":"Nat Chem Biol"},{"issue":"8","key":"1831_CR50","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.tibs.2024.04.002","volume":"49","author":"CH Lin","year":"2024","unstructured":"Lin CH, Chin Y, Zhou M, Sobol RW, Hung MC, Tan M. Protein lipoylation: mitochondria, cuproptosis, and beyond. Trends Biochem Sci. 2024;49(8):729\u201344.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"1831_CR51","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12967-022-03630-1","volume":"20","author":"C Yan","year":"2022","unstructured":"Yan C, Niu Y, Ma L, Tian L, Ma J. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma. J Transl Med. 2022;20(1):452.","journal-title":"J Transl Med"},{"issue":"12","key":"1831_CR52","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1002\/1878-0261.13079","volume":"15","author":"W Gao","year":"2021","unstructured":"Gao W, Huang Z, Duan J, Nice EC, Lin J, Huang C. Elesclomol induces copper-dependent ferroptosis in colorectal cancer cells via degradation of ATP7A. Mol Oncol. 2021;15(12):3527\u201344.","journal-title":"Mol Oncol"},{"issue":"1","key":"1831_CR53","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L, et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther. 2022;7(1):286.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1831_CR54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2025.10.028","volume":"189","author":"AC Lewis","year":"2026","unstructured":"Lewis AC, Gruber E, Franich R, Armstrong J, Kelly MJ, Opazo CM, et al. Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia. Cell. 2026;189(1):215-232.e224.","journal-title":"Cell"},{"key":"1831_CR55","doi-asserted-by":"publisher","first-page":"116115","DOI":"10.1016\/j.biopha.2023.116115","volume":"171","author":"N Liu","year":"2024","unstructured":"Liu N, Chen M. Crosstalk between ferroptosis and cuproptosis: from mechanism to potential clinical application. Biomed Pharmacother. 2024;171:116115.","journal-title":"Biomed Pharmacother"},{"key":"1831_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2020.110236","volume":"191","author":"H Wu","year":"2020","unstructured":"Wu H, Guo H, Liu H, Cui H, Fang J, Zuo Z, et al. Copper sulfate-induced endoplasmic reticulum stress promotes hepatic apoptosis by activating CHOP, JNK and caspase-12 signaling pathways. Ecotoxicol Environ Saf. 2020;191:110236.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"1","key":"1831_CR57","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-025-01726-x","volume":"18","author":"J Tang","year":"2025","unstructured":"Tang J, Zhuang Y, Zhang Y, Hu H, Wang H, Xu H, et al. Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications. J Hematol Oncol. 2025;18(1):77.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1831_CR58","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41419-021-03397-1","volume":"12","author":"J Dong","year":"2021","unstructured":"Dong J, Wang X, Xu C, Gao M, Wang S, Zhang J, et al. Inhibiting NLRP3 inflammasome activation prevents copper-induced neuropathology in a murine model of Wilson\u2019s disease. Cell Death Dis. 2021;12(1):87.","journal-title":"Cell Death Dis"},{"key":"1831_CR59","doi-asserted-by":"publisher","first-page":"124888","DOI":"10.1016\/j.jhazmat.2020.124888","volume":"408","author":"F Yang","year":"2021","unstructured":"Yang F, Liao J, Yu W, Qiao N, Guo J, Han Q, et al. Exposure to copper induces mitochondria-mediated apoptosis by inhibiting mitophagy and the PINK1\/parkin pathway in chicken (Gallus gallus) livers. J Hazard Mater. 2021;408:124888.","journal-title":"J Hazard Mater"},{"issue":"1","key":"1831_CR60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13402-025-01138-6","volume":"49","author":"X Zhou","year":"2026","unstructured":"Zhou X, Peng S. The cross-talk and interplay between ferroptosis and cuproptosis in tumor and therapeutics. Cell Oncol (Dordr). 2026;49(1):19.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"1831_CR61","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-023-02720-2","volume":"42","author":"W Wang","year":"2023","unstructured":"Wang W, Lu K, Jiang X, Wei Q, Zhu L, Wang X, et al. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer. J Exp Clin Cancer Res. 2023;42(1):142.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"1831_CR62","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25(6):424\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"1831_CR63","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"1","key":"1831_CR64","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12943-024-02130-8","volume":"23","author":"X Zhang","year":"2024","unstructured":"Zhang X, Tang B, Luo J, Yang Y, Weng Q, Fang S, et al. Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope. Mol Cancer. 2024;23(1):255.","journal-title":"Mol Cancer"},{"issue":"1","key":"1831_CR65","doi-asserted-by":"publisher","first-page":"117","DOI":"10.7150\/jca.113442","volume":"17","author":"J Cao","year":"2026","unstructured":"Cao J, Deng J, Li X, Chen Y, Wang J, Chong Y, et al. Disulfiram\/copper combination as a potential therapeutic approach for hepatocellular carcinoma: targeting the ATF3-mitochondrial cell death pathway. J Cancer. 2026;17(1):117\u201330.","journal-title":"J Cancer"},{"key":"1831_CR66","doi-asserted-by":"publisher","first-page":"106731","DOI":"10.1016\/j.biocel.2024.106731","volume":"179","author":"B Sun","year":"2025","unstructured":"Sun B, Wang Y, Chen H, Huang Q, An C, Zhan Q, et al. Disulfiram\/copper induces BAK-mediated caspase-independent apoptosis in MCF-7 cells. Int J Biochem Cell Biol. 2025;179:106731.","journal-title":"Int J Biochem Cell Biol"},{"issue":"16","key":"1831_CR67","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1021\/ja109413c","volume":"133","author":"S Tardito","year":"2011","unstructured":"Tardito S, Bassanetti I, Bignardi C, Elviri L, Tegoni M, Mucchino C, et al. Copper binding agents acting as copper ionophores lead to caspase inhibition and paraptotic cell death in human cancer cells. J Am Chem Soc. 2011;133(16):6235\u201342.","journal-title":"J Am Chem Soc"},{"issue":"8","key":"1831_CR68","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1158\/1535-7163.MCT-08-0298","volume":"7","author":"JR Kirshner","year":"2008","unstructured":"Kirshner JR, He S, Balasubramanyam V, Kepros J, Yang CY, Zhang M, et al. Elesclomol induces cancer cell apoptosis through oxidative stress. Mol Cancer Ther. 2008;7(8):2319\u201327.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"1831_CR69","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13046-021-02031-4","volume":"40","author":"M Buccarelli","year":"2021","unstructured":"Buccarelli M, D\u2019Alessandris QG, Matarrese P, Mollinari C, Signore M, Cappannini A, et al. Elesclomol-induced increase of mitochondrial reactive oxygen species impairs glioblastoma stem-like cell survival and tumor growth. J Exp Clin Cancer Res. 2021;40(1):228.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"1831_CR70","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41556-020-0481-4","volume":"22","author":"T Tsang","year":"2020","unstructured":"Tsang T, Posimo JM, Gudiel AA, Cicchini M, Feldser DM, Brady DC. Copper is an essential regulator of the autophagic kinases ULK1\/2 to drive lung adenocarcinoma. Nat Cell Biol. 2020;22(4):412\u201324.","journal-title":"Nat Cell Biol"},{"issue":"7","key":"1831_CR71","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1158\/1541-7786.MCR-21-0250","volume":"20","author":"T Tsang","year":"2022","unstructured":"Tsang T, Gu X, Davis CI, Posimo JM, Miller ZA, Brady DC. BRAFV600E-driven lung adenocarcinoma requires copper to sustain autophagic signaling and processing. Mol Cancer Res. 2022;20(7):1096\u2013107.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"1831_CR72","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12568","volume":"52","author":"Z Yu","year":"2019","unstructured":"Yu Z, Zhou R, Zhao Y, Pan Y, Liang H, Zhang JS, et al. Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death. Cell Prolif. 2019;52(2):e12568.","journal-title":"Cell Prolif"},{"issue":"9","key":"1831_CR73","doi-asserted-by":"publisher","first-page":"e23145","DOI":"10.1096\/fj.202300980R","volume":"37","author":"H Wen","year":"2023","unstructured":"Wen H, Qu C, Wang Z, Gao H, Liu W, Wang H, et al. Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT\/mTOR pathway in prostate cancer. Faseb J. 2023;37(9):e23145.","journal-title":"Faseb J"},{"key":"1831_CR74","doi-asserted-by":"publisher","first-page":"752825","DOI":"10.3389\/fphar.2021.752825","volume":"12","author":"Y Hu","year":"2021","unstructured":"Hu Y, Qian Y, Wei J, Jin T, Kong X, Cao H, et al. The disulfiram\/copper complex induces autophagic cell death in colorectal cancer by targeting ULK1. Front Pharmacol. 2021;12:752825.","journal-title":"Front Pharmacol"},{"key":"1831_CR75","doi-asserted-by":"publisher","first-page":"102284","DOI":"10.1016\/j.redox.2022.102284","volume":"52","author":"F Xia","year":"2022","unstructured":"Xia F, Fu Y, Xie H, Chen Y, Fang D, Zhang W, et al. Suppression of ATG4B by copper inhibits autophagy and involves in Mallory body formation. Redox Biol. 2022;52:102284.","journal-title":"Redox Biol"},{"issue":"1","key":"1831_CR76","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12943-024-02106-8","volume":"23","author":"Z Lin","year":"2024","unstructured":"Lin Z, Li G, Jiang K, Li Z, Liu T. Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications. Mol Cancer. 2024;23(1):191.","journal-title":"Mol Cancer"},{"key":"1831_CR77","doi-asserted-by":"publisher","DOI":"10.1093\/mtomcs\/mfac037","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, He J, Jin J, Ren C. Recent advances in the application of metallomics in diagnosis and prognosis of human cancer. Metallomics. 2022. https:\/\/doi.org\/10.1093\/mtomcs\/mfac037.","journal-title":"Metallomics"},{"key":"1831_CR78","doi-asserted-by":"publisher","first-page":"118152","DOI":"10.1016\/j.trac.2025.118152","volume":"184","author":"K Kozlica","year":"2025","unstructured":"Kozlica K, \u0160\u010dan\u010dar RM, Reber\u0161ek M, \u010cema\u017ear M, Valentinuzzi KU, \u0160\u010dan\u010dar J. Advances in copper speciation, isotopic ratio measurement, bioimaging, and single-cell analysis \u2013 a critical review. TrAC Trends Anal Chem. 2025;184:118152.","journal-title":"TrAC Trends Anal Chem"},{"issue":"2","key":"1831_CR79","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00216-024-05652-8","volume":"417","author":"S Escudero-Cernuda","year":"2025","unstructured":"Escudero-Cernuda S, Clases D, Eiro N, Gonz\u00e1lez LO, Fraile M, Vizoso FJ, et al. Quantitative distribution of essential elements and non-essential metals in breast cancer tissues by LA-ICP-TOF-MS. Anal Bioanal Chem. 2025;417(2):361\u201371.","journal-title":"Anal Bioanal Chem"},{"issue":"7","key":"1831_CR80","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1073\/pnas.0607238104","volume":"104","author":"L Finney","year":"2007","unstructured":"Finney L, Mandava S, Ursos L, Zhang W, Rodi D, Vogt S, et al. X-ray fluorescence microscopy reveals large-scale relocalization and extracellular translocation of cellular copper during angiogenesis. Proc Natl Acad Sci. 2007;104(7):2247\u201352.","journal-title":"Proc Natl Acad Sci"},{"issue":"14","key":"1831_CR81","doi-asserted-by":"publisher","first-page":"6836","DOI":"10.1073\/pnas.1817473116","volume":"116","author":"V Shanbhag","year":"2019","unstructured":"Shanbhag V, Jasmer-McDonald K, Zhu S, Martin AL, Gudekar N, Khan A, et al. ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis. Proc Natl Acad Sci U S A. 2019;116(14):6836\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1831_CR82","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1053\/j.gastro.2023.11.302","volume":"166","author":"M Lewinska","year":"2024","unstructured":"Lewinska M, Zhuravleva E, Satriano L, Martinez MB, Bhatt DK, Oliveira D, et al. Fibroblast-derived lysyl oxidase increases oxidative phosphorylation and stemness in cholangiocarcinoma. Gastroenterology. 2024;166(5):886-901.e887.","journal-title":"Gastroenterology"},{"issue":"48","key":"1831_CR83","doi-asserted-by":"publisher","first-page":"19507","DOI":"10.1073\/pnas.1318431110","volume":"110","author":"S Ishida","year":"2013","unstructured":"Ishida S, Andreux P, Poitry-Yamate C, Auwerx J, Hanahan D. Bioavailable copper modulates oxidative phosphorylation and growth of tumors. Proc Natl Acad Sci U S A. 2013;110(48):19507\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1831_CR84","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","volume":"22","author":"EJ Ge","year":"2022","unstructured":"Ge EJ, Bush AI, Casini A, Cobine PA, Cross JR, DeNicola GM, et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer. 2022;22(2):102\u201313.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1831_CR85","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther. 2023;8(1):455.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"1831_CR86","doi-asserted-by":"publisher","first-page":"101314","DOI":"10.1016\/j.jbc.2021.101314","volume":"297","author":"M Grasso","year":"2021","unstructured":"Grasso M, Bond GJ, Kim YJ, Boyd S, Matson Dzebo M, Valenzuela S, et al. The copper chaperone CCS facilitates copper binding to MEK1\/2 to promote kinase activation. J Biol Chem. 2021;297(6):101314.","journal-title":"J Biol Chem"},{"issue":"47","key":"1831_CR87","doi-asserted-by":"publisher","first-page":"e06201","DOI":"10.1002\/advs.202506201","volume":"12","author":"X Zhang","year":"2025","unstructured":"Zhang X, Su Y, Yang W, Song Z, Sun Z, Wu X, et al. Disruption of NF-\u03baB-mediated copper homeostasis sensitizes breast cancer to cuproptosis. Adv Sci (Weinh). 2025;12(47):e06201.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"1831_CR88","doi-asserted-by":"publisher","first-page":"16","DOI":"10.17305\/bb.2024.10536","volume":"25","author":"J Xie","year":"2024","unstructured":"Xie J, Shao Z, Li C, Zeng C, Xu B. Cuproptosis-related gene ATOX1 promotes MAPK signaling and diffuse large B-cell lymphoma proliferation via modulating copper transport. Biomol Biomed. 2024;25(1):16\u201328.","journal-title":"Biomol Biomed"},{"key":"1831_CR89","doi-asserted-by":"publisher","first-page":"4158415","DOI":"10.1155\/2019\/4158415","volume":"2019","author":"F He","year":"2019","unstructured":"He F, Chang C, Liu B, Li Z, Li H, Cai N, et al. Copper (II) ions activate ligand-independent receptor tyrosine kinase (RTK) signaling pathway. Biomed Res Int. 2019;2019:4158415.","journal-title":"Biomed Res Int"},{"issue":"8","key":"1831_CR90","first-page":"630","volume":"13","author":"Q Ouyang","year":"2025","unstructured":"Ouyang Q, Jia S, Zhu Q, Li Y, Zi H, Chen S, et al. ATOX1 promotes hepatocellular carcinoma carcinogenesis via activation of the c-Myb\/PI3K\/AKT signaling pathway. J Clin Transl Hepatol. 2025;13(8):630\u201343.","journal-title":"J Clin Transl Hepatol"},{"issue":"18","key":"1831_CR91","doi-asserted-by":"publisher","first-page":"e2004303","DOI":"10.1002\/advs.202004303","volume":"8","author":"J Guo","year":"2021","unstructured":"Guo J, Cheng J, Zheng N, Zhang X, Dai X, Zhang L, et al. Copper promotes tumorigenesis by activating the PDK1-AKT oncogenic pathway in a copper transporter 1 dependent manner. Adv Sci (Weinh). 2021;8(18):e2004303.","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"1831_CR92","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.abb.2004.01.004","volume":"423","author":"EA Ostrakhovitch","year":"2004","unstructured":"Ostrakhovitch EA, Cherian MG. Differential regulation of signal transduction pathways in wild type and mutated p53 breast cancer epithelial cells by copper and zinc. Arch Biochem Biophys. 2004;423(2):351\u201361.","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"1831_CR93","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728\u201341.","journal-title":"Cell"},{"key":"1831_CR94","doi-asserted-by":"publisher","first-page":"101170","DOI":"10.1016\/j.drup.2024.101170","volume":"78","author":"X Niu","year":"2025","unstructured":"Niu X, You Q, Hou K, Tian Y, Wei P, Zhu Y, et al. Autophagy in cancer development, immune evasion, and drug resistance. Drug Resist Updat. 2025;78:101170.","journal-title":"Drug Resist Updat"},{"issue":"10","key":"1831_CR95","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41571-025-01058-2","volume":"22","author":"EW Thompson","year":"2025","unstructured":"Thompson EW, Redfern AD, Brabletz S, Berx G, Agarwal V, Ganesh K, et al. EMT and cancer: what clinicians should know. Nat Rev Clin Oncol. 2025;22(10):711\u201333.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1831_CR96","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12943-023-01793-z","volume":"22","author":"A Akhmetkaliyev","year":"2023","unstructured":"Akhmetkaliyev A, Alibrahim N, Shafiee D, Tulchinsky E. EMT\/MET plasticity in cancer and go-or-grow decisions in quiescence: the two sides of the same coin? Mol Cancer. 2023;22(1):90.","journal-title":"Mol Cancer"},{"issue":"1","key":"1831_CR97","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s10495-025-02211-z","volume":"31","author":"HJ Lee","year":"2026","unstructured":"Lee HJ, Park JH, Kim DY, Kim DY, Yi MJ, Choi WS, et al. Copper modulates cell fate through the PLK1-FOXO3a-\u03b2-catenin signaling pathway by differentially regulating cuproptosis and EMT. Apoptosis. 2026;31(1):12.","journal-title":"Apoptosis"},{"issue":"1","key":"1831_CR98","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s13402-022-00738-w","volume":"46","author":"A Vitaliti","year":"2023","unstructured":"Vitaliti A, Roccatani I, Iorio E, Perta N, Gismondi A, Chirico M, et al. AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism. Cell Oncol (Dordr). 2023;46(1):93\u2013115.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"1831_CR99","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13578-023-01083-7","volume":"13","author":"EM Poursani","year":"2023","unstructured":"Poursani EM, Mercatelli D, Raninga P, Bell JL, Saletta F, Kohane FV, et al. Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-\u03b2 signaling pathways in cancer. Cell Biosci. 2023;13(1):132.","journal-title":"Cell Biosci"},{"issue":"11","key":"1831_CR100","doi-asserted-by":"publisher","first-page":"e0206764","DOI":"10.1371\/journal.pone.0206764","volume":"13","author":"S M\u00fcller","year":"2018","unstructured":"M\u00fcller S, Versini A, Sindikubwabo F, Belthier G, Niyomchon S, Pannequin J, et al. Metformin reveals a mitochondrial copper addiction of mesenchymal cancer cells. PLoS ONE. 2018;13(11):e0206764.","journal-title":"PLoS ONE"},{"issue":"2","key":"1831_CR101","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/hep.31236","volume":"72","author":"W Chen","year":"2020","unstructured":"Chen W, Yang A, Jia J, Popov YV, Schuppan D, You H. Lysyl oxidase (LOX) family members: rationale and their potential as therapeutic targets for liver fibrosis. Hepatology. 2020;72(2):729\u201341.","journal-title":"Hepatology"},{"issue":"17","key":"1831_CR102","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-15-2461","volume":"22","author":"M Boufraqech","year":"2016","unstructured":"Boufraqech M, Zhang L, Nilubol N, Sadowski SM, Kotian S, Quezado M, et al. Lysyl oxidase (LOX) transcriptionally regulates SNAI2 expression and TIMP4 secretion in human cancers. Clin Cancer Res. 2016;22(17):4491\u2013504.","journal-title":"Clin Cancer Res"},{"key":"1831_CR103","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejbt.2023.01.002","volume":"63","author":"Y Liu","year":"2023","unstructured":"Liu Y, Liu X, Chen F, Nian W, Huang X, Yang Q, et al. LOXL2 promotes tumor proliferation and metastasis by FAK\/Src signaling in esophageal squamous cell carcinoma. Electron J Biotechnol. 2023;63:18\u201328.","journal-title":"Electron J Biotechnol"},{"key":"1831_CR104","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-pathol-012615-044446","volume":"11","author":"JK Lee","year":"2016","unstructured":"Lee JK, Choi YL, Kwon M, Park PJ. Mechanisms and consequences of cancer genome instability: lessons from genome sequencing studies. Annu Rev Pathol. 2016;11:283\u2013312.","journal-title":"Annu Rev Pathol"},{"key":"1831_CR105","doi-asserted-by":"publisher","first-page":"103256","DOI":"10.1016\/j.redox.2024.103256","volume":"75","author":"J Sailer","year":"2024","unstructured":"Sailer J, Nagel J, Akdogan B, Jauch AT, Engler J, Knolle PA, et al. Deadly excess copper. Redox Biol. 2024;75:103256.","journal-title":"Redox Biol"},{"issue":"6","key":"1831_CR106","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1073\/pnas.93.6.2557","volume":"93","author":"DC Malins","year":"1996","unstructured":"Malins DC, Polissar NL, Gunselman SJ. Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc Natl Acad Sci. 1996;93(6):2557\u201363.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"1831_CR107","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/mnfr.200600107","volume":"51","author":"T Schwerdtle","year":"2007","unstructured":"Schwerdtle T, Hamann I, Jahnke G, Walter I, Richter C, Parsons JL, et al. Impact of copper on the induction and repair of oxidative DNA damage, poly(ADP-ribosyl)ation and PARP-1 activity. Mol Nutr Food Res. 2007;51(2):201\u201310.","journal-title":"Mol Nutr Food Res"},{"key":"1831_CR108","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.taap.2017.05.031","volume":"331","author":"X Ding","year":"2017","unstructured":"Ding X, Zhou X, Cooper KL, Huestis J, Hudson LG, Liu KJ. Differential sensitivities of cellular XPA and PARP-1 to arsenite inhibition and zinc rescue. Toxicol Appl Pharmacol. 2017;331:108\u201315.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1831_CR109","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semcancer.2021.05.009","volume":"76","author":"X Zhou","year":"2021","unstructured":"Zhou X, Speer RM, Volk L, Hudson LG, Liu KJ. Arsenic co-carcinogenesis: inhibition of DNA repair and interaction with zinc finger proteins. Semin Cancer Biol. 2021;76:86\u201398.","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"1831_CR110","doi-asserted-by":"publisher","first-page":"e7052","DOI":"10.1371\/journal.pone.0007052","volume":"4","author":"F Arnesano","year":"2009","unstructured":"Arnesano F, Scintilla S, Cal\u00f2 V, Bonfrate E, Ingrosso C, Losacco M, et al. Copper-triggered aggregation of ubiquitin. PLoS ONE. 2009;4(9):e7052.","journal-title":"PLoS ONE"},{"issue":"1","key":"1831_CR111","first-page":"81","volume":"37","author":"Y Xiao","year":"2010","unstructured":"Xiao Y, Chen DI, Zhang X, Cui Q, Fan Y, Bi C, et al. Molecular study on copper-mediated tumor proteasome inhibition and cell death. Int J Oncol. 2010;37(1):81\u20137.","journal-title":"Int J Oncol"},{"key":"1831_CR112","doi-asserted-by":"publisher","first-page":"33444","DOI":"10.1038\/srep33444","volume":"6","author":"AM Santoro","year":"2016","unstructured":"Santoro AM, Monaco I, Attanasio F, Lanza V, Pappalardo G, Tomasello MF, et al. Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study. Sci Rep. 2016;6:33444.","journal-title":"Sci Rep"},{"issue":"9","key":"1831_CR113","doi-asserted-by":"publisher","first-page":"105046","DOI":"10.1016\/j.jbc.2023.105046","volume":"299","author":"MB Dreishpoon","year":"2023","unstructured":"Dreishpoon MB, Bick NR, Petrova B, Warui DM, Cameron A, Booker SJ, et al. FDX1 regulates cellular protein lipoylation through direct binding to LIAS. J Biol Chem. 2023;299(9):105046.","journal-title":"J Biol Chem"},{"key":"1831_CR114","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbpa.2017.11.003","volume":"42","author":"EA Rowland","year":"2018","unstructured":"Rowland EA, Snowden CK, Cristea IM. Protein lipoylation: an evolutionarily conserved metabolic regulator of health and disease. Curr Opin Chem Biol. 2018;42:76\u201385.","journal-title":"Curr Opin Chem Biol"},{"issue":"6","key":"1831_CR115","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41580-024-00700-8","volume":"25","author":"F SM","year":"2024","unstructured":"SM F, Abrami L, Linder ME, Bamji SX, Dickinson BC, van der Goot FG. Mechanisms and functions of protein S-acylation. Nat Rev Mol Cell Biol. 2024;25(6):488\u2013509.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"34","key":"1831_CR116","doi-asserted-by":"publisher","first-page":"20555","DOI":"10.1073\/pnas.2003982117","volume":"117","author":"BD Weiler","year":"2020","unstructured":"Weiler BD, Br\u00fcck MC, Kothe I, Bill E, Lill R, M\u00fchlenhoff U. Mitochondrial [4Fe-4S] protein assembly involves reductive [2Fe-2S] cluster fusion on ISCA1-ISCA2 by electron flow from ferredoxin FDX2. Proc Natl Acad Sci U S A. 2020;117(34):20555\u201365.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1831_CR117","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s42003-025-08101-z","volume":"8","author":"C Wu","year":"2025","unstructured":"Wu C, Long L, Wang M, Shen L, Hu J, Tang H, et al. Copper-mediated SEC14L3 promotes cuproptosis to inhibit hepatocellular carcinoma growth via ERK\/YY1\/FDX1 axis. Commun Biol. 2025;8(1):658.","journal-title":"Commun Biol"},{"key":"1831_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.923737","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang C, Zeng Y, Guo X, Shen H, Zhang J, Wang K, et al. Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker. Front Genet. 2022;13:923737.","journal-title":"Front Genet"},{"issue":"1","key":"1831_CR119","doi-asserted-by":"publisher","first-page":"130872","DOI":"10.1016\/j.bbagen.2025.130872","volume":"1870","author":"Y Zhao","year":"2026","unstructured":"Zhao Y, Zheng R, Luo K, Zhao H, Xiang W. The CEBPA\/FDX1 axis elevates sensitivity to cuproptosis in lung adenocarcinoma cells. Biochimica et Biophysica Acta (BBA) - Gen Subj. 2026;1870(1):130872.","journal-title":"Biochimica et Biophysica Acta (BBA) - Gen Subj"},{"issue":"6","key":"1831_CR120","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4103\/sjg.sjg_169_24","volume":"30","author":"T Huang","year":"2024","unstructured":"Huang T, Zhang Y, Wu Y, Han X, Li L, Guo Z, et al. CEBPB dampens the cuproptosis sensitivity of colorectal cancer cells by facilitating the PI3K\/AKT\/mTOR signaling pathway. Saudi J Gastroenterol. 2024;30(6):381\u20138.","journal-title":"Saudi J Gastroenterol"},{"issue":"8","key":"1831_CR121","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41580-025-00842-3","volume":"26","author":"Y Liu","year":"2025","unstructured":"Liu Y, Stockwell BR, Jiang X, Gu W. p53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases. Nat Rev Mol Cell Biol. 2025;26(8):600\u201314.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1831_CR122","doi-asserted-by":"publisher","first-page":"1584811","DOI":"10.3389\/fonc.2025.1584811","volume":"15","author":"X Liu","year":"2025","unstructured":"Liu X, Qu H, Li J, Sun X, Wang Z, Wang D, et al. p53 enhances elesclomol-Cu-induced cuproptosis in hepatocellular carcinoma via FDXR-mediated FDX1 upregulation. Front Oncol. 2025;15:1584811.","journal-title":"Front Oncol"},{"issue":"9","key":"1831_CR123","doi-asserted-by":"publisher","first-page":"e70472","DOI":"10.1002\/jbt.70472","volume":"39","author":"X Liu","year":"2025","unstructured":"Liu X, Lin Y, Zhang J. VIPR1 induces cuproptosis and inhibits the HIF-1\u03b1 pathway in colon cancer. J Biochem Mol Toxicol. 2025;39(9):e70472.","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"1831_CR124","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun L, Zhang Y, Yang B, Sun S, Zhang P, Luo Z, et al. Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer. Nat Commun. 2023;14(1):6523.","journal-title":"Nat Commun"},{"key":"1831_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-025-09497-4","author":"Q Jiang","year":"2026","unstructured":"Jiang Q, Peng C, Mao W, Yu Z, Feng Y, Li Y, et al. METTL3-mediated m6A modification of FDX1 confers resistance to cuproptosis and promotes hepatocellular carcinoma progression. Commun Biol. 2026. https:\/\/doi.org\/10.1038\/s42003-025-09497-4.","journal-title":"Commun Biol"},{"issue":"1","key":"1831_CR126","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41421-025-00804-1","volume":"11","author":"J Lin","year":"2025","unstructured":"Lin J, Yin Y, Cao J, Zhang Y, Chen J, Chen R, et al. NUDT21 lactylation reprograms alternative polyadenylation to promote cuproptosis resistance. Cell Discov. 2025;11(1):52.","journal-title":"Cell Discov"},{"issue":"1","key":"1831_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03365-z","volume":"44","author":"H Xu","year":"2025","unstructured":"Xu H, Zhao Q, Cai D, Chen X, Zhou X, Gao Y, et al. o8G-modified circKIAA1797 promotes lung cancer development by inhibiting cuproptosis. J Exp Clin Cancer Res. 2025;44(1):110.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"1831_CR128","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s13402-025-01093-2","volume":"48","author":"G Jia","year":"2025","unstructured":"Jia G, Li J, Jiang M, Liu N, Ding N, Jiang X, et al. Unraveling the miR-144-3p\/PUMA pathway: a novel regulator of FDX1-mediated cuproptosis in colorectal cancer. Cell Oncol (Dordr). 2025;48(6):1693\u2013710.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"1831_CR129","doi-asserted-by":"publisher","first-page":"45246","DOI":"10.1038\/s41598-025-29080-5","volume":"15","author":"S Xu","year":"2025","unstructured":"Xu S, Wang L, Wu Y, Xia Y, Wang L, Yu X, et al. LncRNA RP11-199F11.2 promotes high-grade serous ovarian cancer cell proliferation by regulating cuproptosis through FDX1. Sci Rep. 2025;15(1):45246.","journal-title":"Sci Rep"},{"key":"1831_CR130","doi-asserted-by":"publisher","first-page":"103722","DOI":"10.1016\/j.redox.2025.103722","volume":"85","author":"J Ma","year":"2025","unstructured":"Ma J, Zhang Y, Sun Z, Guo H, Li X, Cai J, et al. LncRNA PVT1 promotes cuproptosis through transcriptional activation of FDX1 in colorectal cancer. Redox Biol. 2025;85:103722.","journal-title":"Redox Biol"},{"issue":"11","key":"1831_CR131","first-page":"5590","volume":"13","author":"B Quan","year":"2023","unstructured":"Quan B, Liu W, Yao F, Li M, Tang B, Li J, et al. LINC02362\/hsa-miR-18a-5p\/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma. Am J Cancer Res. 2023;13(11):5590\u2013609.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"1831_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-025-09201-6","volume":"8","author":"A Feng","year":"2025","unstructured":"Feng A, He L, Li Z, Wang Z, Sun M, Zhao Z, et al. TRIM21 promotes K63-linked ubiquitination of ALKBH5 and suppresses cuproptosis via down-regulation of LIAS in esophageal squamous cell carcinoma. Commun Biol. 2025;8(1):1783.","journal-title":"Commun Biol"},{"issue":"40","key":"1831_CR133","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1038\/s41388-024-03139-5","volume":"43","author":"K Du","year":"2024","unstructured":"Du K, Luo Y, Zhang L, Zeng Y, Dai Y, Ren M, et al. m(6)A modification of lipoyltransferase 1 inhibits bladder cancer progression by activating cuproptosis. Oncogene. 2024;43(40):2971\u201385.","journal-title":"Oncogene"},{"issue":"1","key":"1831_CR134","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41419-025-07613-0","volume":"16","author":"Y Gu","year":"2025","unstructured":"Gu Y, Wang H, Xue W, Zhu L, Fu C, Zhang W, et al. Endoplasmic reticulum stress related super-enhancers suppress cuproptosis via glycolysis reprogramming in lung adenocarcinoma. Cell Death Dis. 2025;16(1):316.","journal-title":"Cell Death Dis"},{"issue":"6","key":"1831_CR135","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.ccell.2025.04.013","volume":"43","author":"D Dang","year":"2025","unstructured":"Dang D, Deogharkar A, McKolay J, Smith KS, Panwalkar P, Hoffman S, et al. Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis. Cancer Cell. 2025;43(6):1159-1174.e1158.","journal-title":"Cancer Cell"},{"issue":"5","key":"1831_CR136","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ccell.2025.02.015","volume":"43","author":"Z Yang","year":"2025","unstructured":"Yang Z, Su W, Wei X, Pan Y, Xing M, Niu L, et al. Hypoxia inducible factor-1\u03b1 drives cancer resistance to cuproptosis. Cancer Cell. 2025;43(5):937-954.e939.","journal-title":"Cancer Cell"},{"issue":"1","key":"1831_CR137","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41419-025-07523-1","volume":"16","author":"W Yu","year":"2025","unstructured":"Yu W, Yin S, Tang H, Li H, Zhang Z, Yang K. PER2 interaction with HSP70 promotes cuproptosis in oral squamous carcinoma cells by decreasing AKT stability. Cell Death Dis. 2025;16(1):192.","journal-title":"Cell Death Dis"},{"issue":"34","key":"1831_CR138","doi-asserted-by":"publisher","first-page":"109825","DOI":"10.3748\/wjg.v31.i34.109825","volume":"31","author":"PT Xiao","year":"2025","unstructured":"Xiao PT, Li CF, Liu YD, Zhong J, Cui XL, Liu C, et al. B cell CLL\/lymphoma 10 promotes colorectal cancer cell proliferation and regulates cuproptosis sensitivity through the NF-\u03baB signaling pathway. World J Gastroenterol. 2025;31(34):109825.","journal-title":"World J Gastroenterol"},{"key":"1831_CR139","doi-asserted-by":"publisher","first-page":"939956","DOI":"10.3389\/fgene.2022.939956","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Lu Y, Dai Y, Shen Y, Zeng C, Liu X, et al. A comprehensive analysis and validation of cuproptosis-associated genes across cancers: overall survival, the tumor microenvironment, stemness scores, and drug sensitivity. Front Genet. 2022;13:939956.","journal-title":"Front Genet"},{"key":"1831_CR140","doi-asserted-by":"publisher","first-page":"1174762","DOI":"10.3389\/fimmu.2023.1174762","volume":"14","author":"J Yang","year":"2023","unstructured":"Yang J, Liu K, Yang L, Ji J, Qin J, Deng H, et al. Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing. Front Immunol. 2023;14:1174762.","journal-title":"Front Immunol"},{"issue":"1","key":"1831_CR141","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12967-023-04204-5","volume":"21","author":"R Wang","year":"2023","unstructured":"Wang R, Xu K, Chen Q, Hu Q, Zhang J, Guan X. Cuproptosis engages in c-Myc-mediated breast cancer stemness. J Transl Med. 2023;21(1):409.","journal-title":"J Transl Med"},{"issue":"11","key":"1831_CR142","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41418-024-01341-2","volume":"31","author":"YT Liu","year":"2024","unstructured":"Liu YT, Chen L, Li SJ, Wang WY, Wang YY, Yang QC, et al. Dysregulated Wnt\/\u03b2-catenin signaling confers resistance to cuproptosis in cancer cells. Cell Death Differ. 2024;31(11):1452\u201366.","journal-title":"Cell Death Differ"},{"key":"1831_CR143","doi-asserted-by":"publisher","DOI":"10.1172\/JCI192599","author":"F Yuan","year":"2026","unstructured":"Yuan F, Wu X, Yuan H, Wang D, Huang T, Zhang P, et al. Glioblastoma stem cells resist cuproptosis with circadian variation of copper levels. J Clin Invest. 2026. https:\/\/doi.org\/10.1172\/JCI192599.","journal-title":"J Clin Invest"},{"issue":"10","key":"1831_CR144","doi-asserted-by":"publisher","DOI":"10.3390\/cells14100717","volume":"14","author":"M Milella","year":"2025","unstructured":"Milella M, Rutigliano M, Pandolfo SD, Aveta A, Crocetto F, Ferro M, et al. The metabolic landscape of cancer stem cells: insights and implications for therapy. Cells. 2025;14(10):717.","journal-title":"Cells"},{"issue":"35","key":"1831_CR145","doi-asserted-by":"publisher","first-page":"e02501","DOI":"10.1002\/advs.202502501","volume":"12","author":"L Li","year":"2025","unstructured":"Li L, Wang Y, Tian R, Yang T, Liu Y, Shan B, et al. TRIM21-mediated K11-linked ubiquitination of ID1 suppresses tumorigenesis and promotes cuproptosis in esophageal squamous cell carcinoma. Adv Sci (Weinh). 2025;12(35):e02501.","journal-title":"Adv Sci (Weinh)"},{"issue":"21","key":"1831_CR146","doi-asserted-by":"publisher","first-page":"e2415983","DOI":"10.1002\/advs.202415983","volume":"12","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Dong C, Shen X, Wang P, Chen T, Li W, et al. Targeting PTBP3-mediated alternative splicing of COX11 induces cuproptosis for inhibiting gastric cancer peritoneal metastasis. Adv Sci (Weinh). 2025;12(21):e2415983.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"1831_CR147","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13046-024-02972-6","volume":"43","author":"X Wang","year":"2024","unstructured":"Wang X, Shi Y, Shi H, Liu X, Liao A, Liu Z, et al. MUC20 regulated by extrachromosomal circular DNA attenuates proteasome inhibitor resistance of multiple myeloma by modulating cuproptosis. J Exp Clin Cancer Res. 2024;43(1):68.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"1831_CR148","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41388-025-03660-1","volume":"45","author":"J Luo","year":"2026","unstructured":"Luo J, Xu X, Chen Y, Huang Y, Huang Y, Zhang Y, et al. YTHDC2 inhibits the resistance of lung cancer to EGFR-TKI through cuproptosis. Oncogene. 2026;45(3):431\u201345.","journal-title":"Oncogene"},{"issue":"2","key":"1831_CR149","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cbpa.2010.01.003","volume":"14","author":"S Lutsenko","year":"2010","unstructured":"Lutsenko S. Human copper homeostasis: a network of interconnected pathways. Curr Opin Chem Biol. 2010;14(2):211\u20137.","journal-title":"Curr Opin Chem Biol"},{"key":"1831_CR150","doi-asserted-by":"publisher","first-page":"101900","DOI":"10.1016\/j.redox.2021.101900","volume":"42","author":"K Lossow","year":"2021","unstructured":"Lossow K, Schwarz M, Kipp AP. Are trace element concentrations suitable biomarkers for the diagnosis of cancer? Redox Biol. 2021;42:101900.","journal-title":"Redox Biol"},{"issue":"5","key":"1831_CR151","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325\u201337.","journal-title":"Nat Rev Cancer"},{"key":"1831_CR152","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.freeradbiomed.2025.12.019","volume":"244","author":"Y Lu","year":"2025","unstructured":"Lu Y, Li Y, Sun X, Li X, Zhao S, Fang Y, et al. Mitochondrial uncoupling sensitizes gastric cancer cells to elesclomol-induced cuproptosis via FDX1\/DLAT upregulation. Free Radic Biol Med. 2025;244:284\u201395.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1831_CR153","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.molcel.2024.11.013","volume":"85","author":"Q Liao","year":"2025","unstructured":"Liao Q, Deng J, Tong J, Gan Y, Hong W, Dong H, et al. p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosis. Mol Cell. 2025;85(1):132-149.e137.","journal-title":"Mol Cell"},{"key":"1831_CR154","doi-asserted-by":"publisher","first-page":"114301","DOI":"10.1016\/j.biopha.2023.114301","volume":"159","author":"W Yang","year":"2023","unstructured":"Yang W, Wang Y, Huang Y, Yu J, Wang T, Li C, et al. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer. Biomed Pharmacother. 2023;159:114301.","journal-title":"Biomed Pharmacother"},{"issue":"17","key":"1831_CR155","doi-asserted-by":"publisher","first-page":"2408106","DOI":"10.1002\/advs.202408106","volume":"12","author":"Z Sun","year":"2025","unstructured":"Sun Z, Xu H, Lu G, Yang C, Gao X, Zhang J, et al. AKT1 phosphorylates FDX1 to promote cuproptosis resistance in triple-negative breast cancer. Adv Sci. 2025;12(17):2408106.","journal-title":"Adv Sci"},{"issue":"4","key":"1831_CR156","first-page":"e70193","volume":"8","author":"Q Wang","year":"2025","unstructured":"Wang Q, Li F, Tiwari AK, Babu RJ. An up-to-date review of elesclomol and its nano-formulations in cancer therapy. Cancer Rep. 2025;8(4):e70193.","journal-title":"Cancer Rep"},{"issue":"5","key":"1831_CR157","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1021\/jacsau.5c00035","volume":"5","author":"C Lee","year":"2025","unstructured":"Lee C, Xiao Z, Lim I, Wang T, Aghaei P, Burke PJ, et al. Copper chelation induces morphology change in mitochondria of triple-negative breast cancer. JACS Au. 2025;5(5):2102\u201313.","journal-title":"JACS Au"},{"issue":"9","key":"1831_CR158","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41419-023-06110-6","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Shen M, Wu L, Yang H, Yao Y, Yang Q, et al. Stromal cells in the tumor microenvironment: accomplices of tumor progression? Cell Death Dis. 2023;14(9):587.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1831_CR159","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2022.09.002","volume":"9","author":"Y Gabai","year":"2023","unstructured":"Gabai Y, Assouline B, Ben-Porath I. Senescent stromal cells: roles in the tumor microenvironment. Trends Cancer. 2023;9(1):28\u201341.","journal-title":"Trends Cancer"},{"issue":"1","key":"1831_CR160","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-022-01252-0","volume":"15","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhang H, Wang J, Liu Y, Luo T, Hua H. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J Hematol Oncol. 2022;15(1):34.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"1831_CR161","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41419-020-2404-5","volume":"11","author":"YY Niu","year":"2020","unstructured":"Niu YY, Zhang YY, Zhu Z, Zhang XQ, Liu X, Zhu SY, et al. Elevated intracellular copper contributes a unique role to kidney fibrosis by lysyl oxidase mediated matrix crosslinking. Cell Death Dis. 2020;11(3):211.","journal-title":"Cell Death Dis"},{"key":"1831_CR162","doi-asserted-by":"publisher","first-page":"122720","DOI":"10.1016\/j.biomaterials.2024.122720","volume":"312","author":"C Wu","year":"2025","unstructured":"Wu C, Huang Z, Chen J, Li N, Cai Y, Chen J, et al. Efficiently directing differentiation and homing of mesenchymal stem cells to boost cartilage repair in osteoarthritis via a nanoparticle and peptide dual-engineering strategy. Biomaterials. 2025;312:122720.","journal-title":"Biomaterials"},{"issue":"1","key":"1831_CR163","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15(1):174.","journal-title":"J Hematol Oncol"},{"key":"1831_CR164","doi-asserted-by":"publisher","first-page":"216859","DOI":"10.1016\/j.canlet.2024.216859","volume":"591","author":"Q Qin","year":"2024","unstructured":"Qin Q, Yu R, Eriksson JE, Tsai HI, Zhu H. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: challenges and opportunities. Cancer Lett. 2024;591:216859.","journal-title":"Cancer Lett"},{"issue":"10","key":"1831_CR165","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41419-022-05351-1","volume":"13","author":"T Zhang","year":"2022","unstructured":"Zhang T, Ren Y, Yang P, Wang J, Zhou H. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Cell Death Dis. 2022;13(10):897.","journal-title":"Cell Death Dis"},{"key":"1831_CR166","doi-asserted-by":"publisher","first-page":"101267","DOI":"10.1016\/j.neo.2025.101267","volume":"72","author":"C Xu","year":"2026","unstructured":"Xu C, Li T, Zhang L, Zhang Q, Cai S, Fu Q, et al. LOXL2+ cancer-associated fibroblasts shape WNT signaling to drive chemoresistance and poor outcomes in colorectal cancer: insights from multi-omics and epidemiological analyses. Neoplasia. 2026;72:101267.","journal-title":"Neoplasia"},{"issue":"21","key":"1831_CR167","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1158\/1078-0432.CCR-14-3096","volume":"21","author":"S Torres","year":"2015","unstructured":"Torres S, Garcia-Palmero I, Herrera M, Bartolom\u00e9 RA, Pe\u00f1a C, Fernandez-Ace\u00f1ero MJ, et al. LOXL2 is highly expressed in cancer-associated fibroblasts and associates to poor colon cancer survival. Clin Cancer Res. 2015;21(21):4892\u2013902.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1831_CR168","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.canlet.2014.08.014","volume":"354","author":"H Kasashima","year":"2014","unstructured":"Kasashima H, Yashiro M, Kinoshita H, Fukuoka T, Morisaki T, Masuda G, et al. Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer. Cancer Lett. 2014;354(2):438\u201346.","journal-title":"Cancer Lett"},{"issue":"1","key":"1831_CR169","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41368-023-00236-1","volume":"15","author":"X Liu","year":"2023","unstructured":"Liu X, Li J, Yang X, Li X, Kong J, Qi D, et al. Carcinoma-associated fibroblast-derived lysyl oxidase-rich extracellular vesicles mediate collagen crosslinking and promote epithelial-mesenchymal transition via p-FAK\/p-paxillin\/YAP signaling. Int J Oral Sci. 2023;15(1):32.","journal-title":"Int J Oral Sci"},{"issue":"8","key":"1831_CR170","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","volume":"14","author":"J Prakash","year":"2024","unstructured":"Prakash J, Shaked Y. The interplay between extracellular matrix remodeling and cancer therapeutics. Cancer Discov. 2024;14(8):1375\u201388.","journal-title":"Cancer Discov"},{"issue":"1","key":"1831_CR171","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12967-021-03181-x","volume":"19","author":"JY Zhang","year":"2021","unstructured":"Zhang JY, Zhu WW, Wang MY, Zhai RD, Wang Q, Shen WL, et al. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness. J Transl Med. 2021;19(1):513.","journal-title":"J Transl Med"},{"issue":"1","key":"1831_CR172","doi-asserted-by":"publisher","first-page":"109298","DOI":"10.1016\/j.identj.2025.109298","volume":"76","author":"KK Cedric","year":"2026","unstructured":"Cedric KK, Sun S, Jin D, Bao S, Sun B, Zhou J, et al. LOX from salivary adenoid cystic carcinoma-associated fibroblast promotes fibrosis in the pulmonary pre-metastatic niche. Int Dent J. 2026;76(1):109298.","journal-title":"Int Dent J"},{"issue":"1","key":"1831_CR173","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/nyas.14358","volume":"1473","author":"H Ghasemi","year":"2020","unstructured":"Ghasemi H, Mousavibahar SH, Hashemnia M, Karimi J, Khodadadi I, Mirzaei F, et al. Tissue stiffness contributes to YAP activation in bladder cancer patients undergoing transurethral resection. Ann N Y Acad Sci. 2020;1473(1):48\u201361.","journal-title":"Ann N Y Acad Sci"},{"issue":"13","key":"1831_CR174","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.1039\/D5CS00083A","volume":"54","author":"L Mao","year":"2025","unstructured":"Mao L, Lu J, Wen X, Song Z, Sun C, Zhao Y, et al. Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond. Chem Soc Rev. 2025;54(13):6282\u2013334.","journal-title":"Chem Soc Rev"},{"issue":"6","key":"1831_CR175","doi-asserted-by":"publisher","first-page":"066010-066010","DOI":"10.1117\/1.AP.7.6.066010","volume":"7","author":"Y Qian","year":"2025","unstructured":"Qian Y, Xie Y, Zhu G, Yin X, Wang J, Gao M, et al. Orthogonal emitted upconversion nanocomposite mediates the generation of oxygen-independent multiple reactive oxygen species for cancer metastasis inhibition. Adv Photonics. 2025;7(6):066010\u2013066010.","journal-title":"Adv Photonics"},{"key":"1831_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.111631","volume":"128","author":"S Zhang","year":"2025","unstructured":"Zhang S, Liu X, Zhang J, Chen K, Li W, Yao Y, et al. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression by targeting ATP7A via exosome-mediated paracrine miR-148b-3p. Cell Signal. 2025;128:111631.","journal-title":"Cell Signal"},{"issue":"1","key":"1831_CR177","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-025-01688-0","volume":"18","author":"H Jia","year":"2025","unstructured":"Jia H, Chen X, Zhang L, Chen M. Cancer associated fibroblasts in cancer development and therapy. J Hematol Oncol. 2025;18(1):36.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1831_CR178","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","volume":"17","author":"F Zhang","year":"2024","unstructured":"Zhang F, Ma Y, Li D, Wei J, Chen K, Zhang E, et al. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution. J Hematol Oncol. 2024;17(1):80.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1831_CR179","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-024-00543-1","volume":"13","author":"S Zheng","year":"2024","unstructured":"Zheng S, Wang W, Shen L, Yao Y, Xia W, Ni C. Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies. Exp Hematol Oncol. 2024;13(1):80.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"1831_CR180","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13046-022-02408-z","volume":"41","author":"X Zhou","year":"2022","unstructured":"Zhou X, Zhang J, Lv W, Zhao C, Xia Y, Wu Y, et al. The pleiotropic roles of adipocyte secretome in remodeling breast cancer. J Exp Clin Cancer Res. 2022;41(1):203.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1831_CR181","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12935-024-03433-y","volume":"24","author":"X Chen","year":"2024","unstructured":"Chen X, Zhang H, Fang Z, Wang D, Song Y, Zhang Q, et al. Adipocytes promote metastasis of breast cancer by attenuating the FOXO1 effects and regulating copper homeostasis. Cancer Cell Int. 2024;24(1):284.","journal-title":"Cancer Cell Int"},{"issue":"8","key":"1831_CR182","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nchembio.2098","volume":"12","author":"L Krishnamoorthy","year":"2016","unstructured":"Krishnamoorthy L, Cotruvo JA Jr., Chan J, Kaluarachchi H, Muchenditsi A, Pendyala VS, et al. Copper regulates cyclic-AMP-dependent lipolysis. Nat Chem Biol. 2016;12(8):586\u201392.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"1831_CR183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.37349\/etat.2024.00201","volume":"5","author":"CM Van Stiphout","year":"2024","unstructured":"Van Stiphout CM, Kelly G, Pallegar NK, Elbakry E, Vilchis-Celis AV, Christian SL, et al. Identification of lysyl oxidase as an adipocyte-secreted mediator that promotes a partial mesenchymal-to-epithelial transition in MDA-MB-231 cells. Explor Target Antitumor Ther. 2024;5(1):1\u201319.","journal-title":"Explor Target Antitumor Ther"},{"issue":"3","key":"1831_CR184","doi-asserted-by":"publisher","first-page":"e80274","DOI":"10.1371\/journal.pone.0080274","volume":"9","author":"E Arner","year":"2014","unstructured":"Arner E, Forrest AR, Ehrlund A, Mejhert N, Itoh M, Kawaji H, et al. Ceruloplasmin is a novel adipokine which is overexpressed in adipose tissue of obese subjects and in obesity-associated cancer cells. PLoS ONE. 2014;9(3):e80274.","journal-title":"PLoS ONE"},{"issue":"36","key":"1831_CR185","doi-asserted-by":"publisher","first-page":"50317","DOI":"10.1021\/acsami.5c11318","volume":"17","author":"S Wang","year":"2025","unstructured":"Wang S, Shen Y, Hu B, Wu Q, Wang N, Wang Z, et al. Light-activated CD36-targeted cuproptosis triggers metabolic-immune synergy for precision breast cancer therapy. ACS Appl Mater Interfaces. 2025;17(36):50317\u201336.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"1831_CR186","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/jcb.10111","volume":"85","author":"JP Rodr\u00edguez","year":"2002","unstructured":"Rodr\u00edguez JP, R\u00edos S, Gonz\u00e1lez M. Modulation of the proliferation and differentiation of human mesenchymal stem cells by copper. J Cell Biochem. 2002;85(1):92\u2013100.","journal-title":"J Cell Biochem"},{"issue":"1","key":"1831_CR187","first-page":"561098","volume":"2013","author":"LA Marquez-Curtis","year":"2013","unstructured":"Marquez-Curtis LA, Janowska-Wieczorek A. Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1\/CXCR4 axis. BioMed Res Int. 2013;2013(1):561098.","journal-title":"BioMed Res Int"},{"issue":"1","key":"1831_CR188","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40164-025-00688-7","volume":"14","author":"L Sun","year":"2025","unstructured":"Sun L, Cao X, Zhou B, Mei J, Zhao X, Li Y, et al. Tumor-associated mesenchymal stem\/stromal cells in tumor microenvironment and carcinogenesis. Exp Hematol Oncol. 2025;14(1):97.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"1831_CR189","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40164-024-00532-4","volume":"13","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang C, Li JJ. Revisiting the role of mesenchymal stromal cells in cancer initiation, metastasis and immunosuppression. Exp Hematol Oncol. 2024;13(1):64.","journal-title":"Exp Hematol Oncol"},{"issue":"6","key":"1831_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101611","volume":"12","author":"Y Han","year":"2025","unstructured":"Han Y, Zhu B, Meng S. Endothelial cell in tumor angiogenesis: origins, mechanisms, and therapeutic implication. Genes Dis. 2025;12(6):101611.","journal-title":"Genes Dis"},{"issue":"38","key":"1831_CR191","doi-asserted-by":"publisher","first-page":"14669","DOI":"10.1074\/jbc.RA118.001764","volume":"293","author":"X Liu","year":"2018","unstructured":"Liu X, Zhang W, Wu Z, Yang Y, Kang YJ. Copper levels affect targeting of hypoxia-inducible factor 1\u03b1 to the promoters of hypoxia-regulated genes. J Biol Chem. 2018;293(38):14669\u201377.","journal-title":"J Biol Chem"},{"issue":"1","key":"1831_CR192","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1038\/s41467-021-23408-1","volume":"12","author":"D Ash","year":"2021","unstructured":"Ash D, Sudhahar V, Youn SW, Okur MN, Das A, O\u2019Bryan JP, et al. The P-type ATPase transporter ATP7A promotes angiogenesis by limiting autophagic degradation of VEGFR2. Nat Commun. 2021;12(1):3091.","journal-title":"Nat Commun"},{"issue":"Suppl_1","key":"1831_CR193","doi-asserted-by":"publisher","first-page":"A4143778","DOI":"10.1161\/circ.150.suppl_1.4143778","volume":"150","author":"A Das","year":"2024","unstructured":"Das A, Varadarajan S, Yadav S, Fulton D, Kelley S, McMenamin M, et al. Abstract 4143778: ROS-dependent SUMOylation of copper chaperone Atox1 orchestrates endothelial inflammatory and angiogenic signaling, promoting neovascularization following ischemic injury. Circulation. 2024;150(Suppl_1):A4143778\u2013A4143778.","journal-title":"Circulation"},{"issue":"1","key":"1831_CR194","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-025-00695-8","volume":"14","author":"M Radandish","year":"2025","unstructured":"Radandish M, Mashhadi N, Aghayan AH, Taghizadeh M, Salehianfard S, Yahyazadeh S, et al. In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy. Exp Hematol Oncol. 2025;14(1):105.","journal-title":"Exp Hematol Oncol"},{"issue":"6","key":"1831_CR195","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/nrc2013","volume":"6","author":"K Aliazis","year":"2025","unstructured":"Aliazis K, Christofides A, Shah R, Yeo YY, Jiang S, Charest A, et al. The tumor microenvironment\u2019s role in the response to immune checkpoint blockade. Nat Rev Cancer. 2025;6(6):924\u201337.","journal-title":"Nat Rev Cancer"},{"key":"1831_CR196","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","volume":"470","author":"X Lei","year":"2020","unstructured":"Lei X, Lei Y, Li JK, Du WX, Li RG, Yang J, et al. Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. Cancer Lett. 2020;470:126\u201333.","journal-title":"Cancer Lett"},{"key":"1831_CR197","doi-asserted-by":"publisher","first-page":"217772","DOI":"10.1016\/j.canlet.2025.217772","volume":"625","author":"X Bai","year":"2025","unstructured":"Bai X, Guo YR, Zhao ZM, Li XY, Dai DQ, Zhang JK, et al. Macrophage polarization in cancer and beyond: from inflammatory signaling pathways to potential therapeutic strategies. Cancer Lett. 2025;625:217772.","journal-title":"Cancer Lett"},{"key":"1831_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.114641","volume":"252","author":"Y Qiu","year":"2025","unstructured":"Qiu Y, Liu H, Han C, Yan Z, Lu Y, Ren L, et al. The effect of copper content in Ti-Cu alloy with bone regeneration ability on the phenotypic transformation of macrophages. Colloids Surf B Biointerfaces. 2025;252:114641.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1831_CR199","doi-asserted-by":"publisher","first-page":"e943738","DOI":"10.12659\/MSM.943738","volume":"30","author":"D Geng","year":"2024","unstructured":"Geng D, Lin R, Wei P, Tang C, Xu Y, Wang L. The role of copper-induced M2 macrophage polarization in protecting cartilage matrix in osteoarthritis. Med Sci Monit. 2024;30:e943738.","journal-title":"Med Sci Monit"},{"issue":"4","key":"1831_CR200","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1007\/s12011-024-04333-y","volume":"203","author":"JX Xu","year":"2025","unstructured":"Xu JX, Ma LJ, Tu LY, Tang QS, Wu B, Jiang LH. The effect of cuproptosis-related proteins on macrophage polarization in mesothelioma is revealed by scRNA-seq. Biol Trace Elem Res. 2025;203(4):1898\u2013908.","journal-title":"Biol Trace Elem Res"},{"issue":"8","key":"1831_CR201","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1039\/D3TB02886K","volume":"12","author":"Y Lu","year":"2024","unstructured":"Lu Y, Fan X, Pan Q, He B, Pu Y. A mitochondria-targeted anticancer copper dithiocarbamate amplifies immunogenic cuproptosis and macrophage polarization. J Mater Chem B. 2024;12(8):2006\u201314.","journal-title":"J Mater Chem B"},{"issue":"36","key":"1831_CR202","doi-asserted-by":"publisher","first-page":"32444","DOI":"10.1021\/acsnano.5c08767","volume":"19","author":"X Zeng","year":"2025","unstructured":"Zeng X, Tang S, Hu G, Pang Y, Lin S, Shangguan S, et al. Reprogramming macrophage function via cholesterol modulation and redox signaling using a multifunctional nanoplatform for postoperative breast cancer management. ACS Nano. 2025;19(36):32444\u201359.","journal-title":"ACS Nano"},{"issue":"1","key":"1831_CR203","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40164-023-00469-0","volume":"13","author":"M Cao","year":"2024","unstructured":"Cao M, Wang Z, Lan W, Xiang B, Liao W, Zhou J, et al. The roles of tissue resident macrophages in health and cancer. Exp Hematol Oncol. 2024;13(1):3.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"1831_CR204","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40164-024-00561-z","volume":"13","author":"Y Shi","year":"2024","unstructured":"Shi Y, Hao D, Qian H, Tao Z. Natural killer cell-based cancer immunotherapy: from basics to clinical trials. Exp Hematol Oncol. 2024;13(1):101.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"1831_CR205","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40164-024-00481-y","volume":"13","author":"J Shang","year":"2024","unstructured":"Shang J, Hu S, Wang X. Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies. Exp Hematol Oncol. 2024;13(1):21.","journal-title":"Exp Hematol Oncol"},{"issue":"5","key":"1831_CR206","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/ajcn\/45.5.997","volume":"45","author":"LD Koller","year":"1987","unstructured":"Koller LD, Mulhern SA, Frankel NC, Steven MG, Williams JR. Immune dysfunction in rats fed a diet deficient in copper. Am J Clin Nutr. 1987;45(5):997\u20131006.","journal-title":"Am J Clin Nutr"},{"key":"1831_CR207","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1491450","volume":"16","author":"DC Dumut","year":"2025","unstructured":"Dumut DC, Hajduch M, Zacharias AM, Duan Q, Frydrych I, Rozankova Z, et al. Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis. Front Immunol. 2025;16:1491450.","journal-title":"Front Immunol"},{"issue":"1","key":"1831_CR208","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40164-024-00511-9","volume":"13","author":"J Hou","year":"2024","unstructured":"Hou J, Xie S, Gao J, Jiang T, Zhu E, Yang X, et al. NK cell transfer overcomes resistance to PD-(L)1 therapy in aged mice. Exp Hematol Oncol. 2024;13(1):48.","journal-title":"Exp Hematol Oncol"},{"issue":"70","key":"1831_CR209","doi-asserted-by":"publisher","first-page":"eabm9409","DOI":"10.1126\/sciimmunol.abm9409","volume":"7","author":"E Kvedaraite","year":"2022","unstructured":"Kvedaraite E, Ginhoux F. Human dendritic cells in cancer. Sci Immunol. 2022;7(70):eabm9409.","journal-title":"Sci Immunol"},{"key":"1831_CR210","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.biomaterials.2019.01.007","volume":"195","author":"P Zhou","year":"2019","unstructured":"Zhou P, Qin J, Zhou C, Wan G, Liu Y, Zhang M, et al. Multifunctional nanoparticles based on a polymeric copper chelator for combination treatment of metastatic breast cancer. Biomaterials. 2019;195:86\u201399.","journal-title":"Biomaterials"},{"issue":"1","key":"1831_CR211","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","volume":"21","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yi M, Niu M, Mei Q, Wu K. Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy. Mol Cancer. 2022;21(1):184.","journal-title":"Mol Cancer"},{"issue":"1","key":"1831_CR212","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40164-024-00505-7","volume":"13","author":"J Lu","year":"2024","unstructured":"Lu J, Luo Y, Rao D, Wang T, Lei Z, Chen X, et al. Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion. Exp Hematol Oncol. 2024;13(1):39.","journal-title":"Exp Hematol Oncol"},{"issue":"5","key":"1831_CR213","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41590-020-0666-9","volume":"21","author":"T Baumann","year":"2020","unstructured":"Baumann T, Dunkel A, Schmid C, Schmitt S, Hiltensperger M, Lohr K, et al. Regulatory myeloid cells paralyze T cells through cell\u2013cell transfer of the metabolite methylglyoxal. Nat Immunol. 2020;21(5):555\u201366.","journal-title":"Nat Immunol"},{"key":"1831_CR214","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-026-03371-8","author":"R Geng","year":"2026","unstructured":"Geng R, Cai H, Ji X, Shen X, Wang Z, Li Z, et al. Blockage of cuproplasia inhibits pancreatic tumour-associated neutrophils infiltration through TRAF6\/STAT3\/CCL2 pathway. Br J Cancer. 2026. https:\/\/doi.org\/10.1038\/s41416-026-03371-8.","journal-title":"Br J Cancer"},{"issue":"6","key":"1831_CR215","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41568-023-00562-w","volume":"23","author":"B Ruf","year":"2023","unstructured":"Ruf B, Greten TF, Korangy F. Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunity. Nat Rev Cancer. 2023;23(6):351\u201371.","journal-title":"Nat Rev Cancer"},{"issue":"15","key":"1831_CR216","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.1073\/pnas.89.15.6794","volume":"89","author":"S Bala","year":"1992","unstructured":"Bala S, Failla ML. Copper deficiency reversibly impairs DNA synthesis in activated T lymphocytes by limiting interleukin 2 activity. Proc Natl Acad Sci U S A. 1992;89(15):6794\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1831_CR217","doi-asserted-by":"publisher","first-page":"106808","DOI":"10.1016\/j.aquatox.2023.106808","volume":"267","author":"L Li","year":"2024","unstructured":"Li L, Shi J, Liu W, Luo Y, Gao S, Liu J-X. Copper overload induces apoptosis and impaired proliferation of T cell in zebrafish. Aquat Toxicol. 2024;267:106808.","journal-title":"Aquat Toxicol"},{"issue":"118","key":"1831_CR218","doi-asserted-by":"publisher","first-page":"eaec2573","DOI":"10.1126\/sciimmunol.aec2573","volume":"11","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Shi F, Tang H, Wang T, Zhao H, Chang J, et al. Copper supports regulatory T cell energetic state to sustain peripheral immune tolerance. Sci Immunol. 2026;11(118):eaec2573.","journal-title":"Sci Immunol"},{"key":"1831_CR219","doi-asserted-by":"publisher","DOI":"10.1093\/jimmun\/vkaf283.2043","author":"L Noyer","year":"2025","unstructured":"Noyer L, Wang L, Jishage M, McDermott M, Pezacki A, Chang CJ, et al. Copper transporter 1 (CTR1) regulates T cell metabolism and pathogenic Th17 cell polarization 4345. J Immunol. 2025. https:\/\/doi.org\/10.1093\/jimmun\/vkaf283.2043.","journal-title":"J Immunol"},{"key":"1831_CR220","doi-asserted-by":"publisher","first-page":"974034","DOI":"10.3389\/fimmu.2022.974034","volume":"13","author":"L Jin","year":"2022","unstructured":"Jin L, Mei W, Liu X, Sun X, Xin S, Zhou Z, et al. Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer. Front Immunol. 2022;13:974034.","journal-title":"Front Immunol"},{"issue":"3","key":"1831_CR221","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10142-023-01210-0","volume":"23","author":"J Wang","year":"2023","unstructured":"Wang J, Li S, Guo Y, Zhao C, Chen Y, Ning W, et al. Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in glioma. Funct Integr Genomics. 2023;23(3):279.","journal-title":"Funct Integr Genomics"},{"issue":"1","key":"1831_CR222","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12920-023-01489-9","volume":"16","author":"F-S Kong","year":"2023","unstructured":"Kong F-S, Ren C-Y, Jia R, Zhou Y, Chen J-H, Ma Y. Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types. BMC Med Genomics. 2023;16(1):61.","journal-title":"BMC Med Genomics"},{"issue":"6","key":"1831_CR223","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cell.2018.10.022","volume":"175","author":"BJ Schmiedel","year":"2018","unstructured":"Schmiedel BJ, Singh D, Madrigal A, Valdovino-Gonzalez AG, White BM, Zapardiel-Gonzalo J, et al. Impact of genetic polymorphisms on human immune cell gene expression. Cell. 2018;175(6):1701-1715.e1716.","journal-title":"Cell"},{"issue":"49","key":"1831_CR224","doi-asserted-by":"publisher","first-page":"33949","DOI":"10.1074\/jbc.M109.070201","volume":"284","author":"C White","year":"2009","unstructured":"White C, Lee J, Kambe T, Fritsche K, Petris MJ. A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity. J Biol Chem. 2009;284(49):33949\u201356.","journal-title":"J Biol Chem"},{"issue":"11","key":"1831_CR225","doi-asserted-by":"publisher","first-page":"e70661","DOI":"10.1096\/fj.202500056R","volume":"39","author":"Y Jing","year":"2025","unstructured":"Jing Y, Shi J, Xie Z, Shen Z, Zhang J, Wang F, et al. ATP7A maintains bactericidal function of neutrophils and macrophages via regulating the formation and activation of phagolysosomes. FASEB J. 2025;39(11):e70661.","journal-title":"FASEB J"},{"issue":"9","key":"1831_CR226","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1039\/C6MT00176A","volume":"8","author":"S Lutsenko","year":"2016","unstructured":"Lutsenko S. Copper trafficking to the secretory pathway. Metallomics. 2016;8(9):840\u201352.","journal-title":"Metallomics"},{"issue":"22","key":"1831_CR227","doi-asserted-by":"publisher","first-page":"6335","DOI":"10.1016\/j.cell.2025.08.013","volume":"188","author":"Y Han","year":"2025","unstructured":"Han Y, Sarkar H, Xu Z, Lopez-Darwin S, Wei Y, Hang X, et al. Tumors hijack macrophages for iron supply to promote bone metastasis and anemia. Cell. 2025;188(22):6335-6354.e6326.","journal-title":"Cell"},{"issue":"1","key":"1831_CR228","doi-asserted-by":"publisher","first-page":"10462","DOI":"10.1038\/s41467-024-54689-x","volume":"15","author":"JRC Rouaen","year":"2024","unstructured":"Rouaen JRC, Salerno A, Shai-Hee T, Murray JE, Castrogiovanni G, McHenry C, et al. Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma. Nat Commun. 2024;15(1):10462.","journal-title":"Nat Commun"},{"issue":"22","key":"1831_CR229","doi-asserted-by":"publisher","first-page":"e2201734","DOI":"10.1002\/advs.202201734","volume":"9","author":"Z Li","year":"2022","unstructured":"Li Z, Lai X, Fu S, Ren L, Cai H, Zhang H, et al. Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency. Adv Sci (Weinh). 2022;9(22):e2201734.","journal-title":"Adv Sci (Weinh)"},{"key":"1831_CR230","doi-asserted-by":"publisher","first-page":"123201","DOI":"10.1016\/j.biomaterials.2025.123201","volume":"319","author":"J Li","year":"2025","unstructured":"Li J, Zhang G, Sun Z, Jiang M, Jia G, Liu H, et al. Immunogenic cuproptosis in cancer immunotherapy via an in situ cuproptosis-inducing system. Biomaterials. 2025;319:123201.","journal-title":"Biomaterials"},{"key":"1831_CR231","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194715","author":"X Gao","year":"2022","unstructured":"Gao X, Huang H, Pan C, Mei Z, Yin S, Zhou L, et al. Disulfiram\/copper induces immunogenic cell death and enhances CD47 blockade in hepatocellular carcinoma. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14194715.","journal-title":"Cancers (Basel)"},{"key":"1831_CR232","doi-asserted-by":"publisher","first-page":"101317","DOI":"10.1016\/j.mtbio.2024.101317","volume":"29","author":"X Lu","year":"2024","unstructured":"Lu X, Deng W, Wang S, Zhao S, Zhu B, Bai B, et al. PEGylated Elesclomol@Cu(\u2161)-based metal-organic framework with effective nanozyme performance and cuproptosis induction efficacy for enhanced PD-L1-based immunotherapy. Mater Today Bio. 2024;29:101317.","journal-title":"Mater Today Bio"},{"issue":"1","key":"1831_CR233","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s42114-024-01138-4","volume":"8","author":"H Zhang","year":"2024","unstructured":"Zhang H, Xia J, Xie L, Hao M, Liang W, Wang S, et al. Mitochondria- and anaerobic glycolysis-targeted self-assembled copper complex nanoparticles for boosting cuproptosis-immunotherapy. Adv Compos Hybrid Mater. 2024;8(1):45.","journal-title":"Adv Compos Hybrid Mater"},{"key":"1831_CR234","doi-asserted-by":"publisher","first-page":"996307","DOI":"10.3389\/fcell.2022.996307","volume":"10","author":"J Liu","year":"2022","unstructured":"Liu J, Liu Y, Wang Y, Kang R, Tang D. HMGB1 is a mediator of cuproptosis-related sterile inflammation. Front Cell Dev Biol. 2022;10:996307.","journal-title":"Front Cell Dev Biol"},{"issue":"17","key":"1831_CR235","doi-asserted-by":"publisher","first-page":"8587","DOI":"10.7150\/thno.62572","volume":"11","author":"C Ji","year":"2021","unstructured":"Ji C, Si J, Xu Y, Zhang W, Yang Y, He X, et al. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation. Theranostics. 2021;11(17):8587\u2013604.","journal-title":"Theranostics"},{"issue":"1","key":"1831_CR236","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-025-01691-5","volume":"18","author":"M Shen","year":"2025","unstructured":"Shen M, Jiang X, Peng Q, Oyang L, Ren Z, Wang J, et al. The cGAS-STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications. J Hematol Oncol. 2025;18(1):40.","journal-title":"J Hematol Oncol"},{"issue":"11","key":"1831_CR237","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/cac2.70067","volume":"45","author":"Y Yan","year":"2025","unstructured":"Yan Y, Tan X, Song B, Yi M, Chu Q, Wu K. Breaking barriers: the cGAS-STING pathway as a novel frontier in cancer immunotherapy. Cancer Commun (Lond). 2025;45(11):1513\u201346.","journal-title":"Cancer Commun (Lond)"},{"issue":"10","key":"1831_CR238","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1021\/jacsau.4c00712","volume":"4","author":"C Zhu","year":"2024","unstructured":"Zhu C, Li J, Sun W, Li D, Wang Y, Shen XC. Signaling mechanism of cuproptosis activating cGAS-STING immune pathway. JACS Au. 2024;4(10):3988\u201399.","journal-title":"JACS Au"},{"issue":"4","key":"1831_CR239","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.7150\/ijbs.105575","volume":"21","author":"M Yuan","year":"2025","unstructured":"Yuan M, Shi L, Liu Y, Xiang K, Zhang Y, Zhou Y, et al. Disulfiram\/copper triggers cGAS-STING innate immunity pathway via ROS-induced DNA damage that potentiates antitumor response to PD-1 checkpoint blockade. Int J Biol Sci. 2025;21(4):1730\u201348.","journal-title":"Int J Biol Sci"},{"key":"1831_CR240","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-026-04203-w","author":"C Li","year":"2026","unstructured":"Li C, Li Y, Wang Z, Wang Y, Guan W, Huang Z. Nanomedicine leverages cuproptosis-mediated cGAS-STING activation to enhance antitumor immunity. J Nanobiotechnol. 2026. https:\/\/doi.org\/10.1186\/s12951-026-04203-w.","journal-title":"J Nanobiotechnol"},{"key":"1831_CR241","doi-asserted-by":"publisher","DOI":"10.1002\/mc.70128","author":"I Lu","year":"2026","unstructured":"Lu I, Zhang J, Chen X, Wang XJ. Harnessing cuproptosis for antitumor immunity: a review of current evidence and therapeutic strategies. Mol Carcinog. 2026. https:\/\/doi.org\/10.1002\/mc.70128.","journal-title":"Mol Carcinog"},{"key":"1831_CR242","doi-asserted-by":"publisher","first-page":"102957","DOI":"10.1016\/j.mtbio.2026.102957","volume":"37","author":"X Luo","year":"2026","unstructured":"Luo X, Wang X, Li S, Chen Q, Song J, Chen J. A precise theranostic nanoplatform amplifies anti-tumor efficacy via copper ionophores and sonodynamic therapy. Mater Today Bio. 2026;37:102957.","journal-title":"Mater Today Bio"},{"issue":"6","key":"1831_CR243","doi-asserted-by":"publisher","first-page":"e02817","DOI":"10.1002\/adhm.202502817","volume":"15","author":"HW Lien","year":"2026","unstructured":"Lien HW, Kuo YY, Chang YH, Huynh TMH, Yalamandala BN, Li TC, et al. Electromagnetic wireless remote control of reprogramming immune dysfunction via N-doped carbon dots-mesoporous silica-mediated cuproptosis and dendritic cell retention. Adv Healthc Mater. 2026;15(6):e02817.","journal-title":"Adv Healthc Mater"},{"key":"1831_CR244","doi-asserted-by":"publisher","DOI":"10.3390\/ph17060678","author":"B Wang","year":"2024","unstructured":"Wang B, Liu Y, Xiong F, Wang C. Improved immunotherapy outcomes via cuproptosis upregulation of HLA-DRA expression: promoting the aggregation of CD4(+) and CD8(+)T lymphocytes in clear cell renal cell carcinoma. Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17060678.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1831_CR245","doi-asserted-by":"publisher","first-page":"111239","DOI":"10.1016\/j.cbi.2024.111239","volume":"403","author":"J Zeng","year":"2024","unstructured":"Zeng J, Chen H, Liu X, Xia H, Chen L, Lin D, et al. Cuproptosis in microsatellite stable colon cancer cells affects the cytotoxicity of CD8(+)T through the WNT signaling pathway. Chem Biol Interact. 2024;403:111239.","journal-title":"Chem Biol Interact"},{"issue":"4","key":"1831_CR246","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41419-024-06644-3","volume":"15","author":"W Guo","year":"2024","unstructured":"Guo W, Jia L, Xie L, Kiang JG, Wang Y, Sun F, et al. Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram\/copper-mediated enhanced immunogenic cell death of breast cancer cells. Cell Death Dis. 2024;15(4):298.","journal-title":"Cell Death Dis"},{"issue":"23","key":"1831_CR247","doi-asserted-by":"publisher","first-page":"e2503208","DOI":"10.1002\/smll.202503208","volume":"21","author":"C Jiang","year":"2025","unstructured":"Jiang C, Li X, Wan S, Ji S, Wang Q, Hu S, et al. Copper-doped polydopamine nanoparticles-mediated GSH\/GPX4-depleted ferroptosis and cuproptosis sensitizes lung tumor to checkpoint blockade immunotherapy. Small. 2025;21(23):e2503208.","journal-title":"Small"},{"key":"1831_CR248","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-026-04267-8","author":"M Tu","year":"2026","unstructured":"Tu M, Deng X, Zhou Z, Li X, Mao S, Lai B, et al. Multifunctional copper-based nanoparticles potentiate colorectal cancer immunotherapy via synergistic metabolic remodeling and cGAS-STING pathway activation. J Nanobiotechnol. 2026. https:\/\/doi.org\/10.1186\/s12951-026-04267-8.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"1831_CR249","doi-asserted-by":"publisher","first-page":"2952331","DOI":"10.1155\/mi\/2952331","volume":"2026","author":"Y Wang","year":"2026","unstructured":"Wang Y, Zhu Y, Wang Y, Liu Y, Wang P, Yu M. Cuproptosis at the crossroads of tumor microenvironment inflammation and metabolic rewiring mechanisms and therapeutic opportunities. Mediators Inflamm. 2026;2026(1):2952331.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"1831_CR250","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s13071-024-06520-1","volume":"17","author":"X Hou","year":"2024","unstructured":"Hou X, Zhou T, Wang Q, Chen P, Zhang M, Wu L, et al. Role of cuproptosis in mediating the severity of experimental malaria-associated acute lung injury\/acute respiratory distress syndrome. Parasit Vectors. 2024;17(1):433.","journal-title":"Parasit Vectors"},{"issue":"18","key":"1831_CR251","doi-asserted-by":"publisher","first-page":"e2417676","DOI":"10.1002\/advs.202417676","volume":"12","author":"S Gao","year":"2025","unstructured":"Gao S, Ge H, Gao L, Gao Y, Tang S, Li Y, et al. Silk fibroin nanoparticles for enhanced cuproptosis and immunotherapy in pancreatic cancer treatment. Adv Sci (Weinh). 2025;12(18):e2417676.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"1831_CR252","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12951-025-03486-9","volume":"23","author":"X Sun","year":"2025","unstructured":"Sun X, Wang X, Li X, Wang Y, Xu R, Shen X, et al. Orchestrated Cu(2+)-coordinated tetracycline-porphyrin self-assembly remodels tumor microenvironment for photo-enhanced immuno-chemodynamic therapy. J Nanobiotechnol. 2025;23(1):419.","journal-title":"J Nanobiotechnol"},{"issue":"5","key":"1831_CR253","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","volume":"23","author":"G Oliveira","year":"2023","unstructured":"Oliveira G, Wu CJ. Dynamics and specificities of T cells in cancer immunotherapy. Nat Rev Cancer. 2023;23(5):295\u2013316.","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"1831_CR254","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1158\/0008-5472.CAN-20-0471","volume":"80","author":"F Voli","year":"2020","unstructured":"Voli F, Valli E, Lerra L, Kimpton K, Saletta F, Giorgi FM, et al. Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion. Cancer Res. 2020;80(19):4129\u201344.","journal-title":"Cancer Res"},{"issue":"1","key":"1831_CR255","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1186\/s12951-024-03059-2","volume":"22","author":"Y Chen","year":"2024","unstructured":"Chen Y, Tian H, Zhang X, Nice EC, Huang C, Zhang H, et al. Copper-coordination driven brain-targeting nanoassembly for efficient glioblastoma multiforme immunotherapy by cuproptosis-mediated tumor immune microenvironment reprogramming. J Nanobiotechnology. 2024;22(1):801.","journal-title":"J Nanobiotechnology"},{"issue":"35","key":"1831_CR256","doi-asserted-by":"publisher","first-page":"e2403520","DOI":"10.1002\/advs.202403520","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, Liu J, Weichselbaum RR, Lin W. Mitochondria-targeted multifunctional nanoparticles combine cuproptosis and programmed cell death-1 downregulation for cancer immunotherapy. Adv Sci (Weinh). 2024;11(35):e2403520.","journal-title":"Adv Sci (Weinh)"},{"key":"1831_CR257","doi-asserted-by":"publisher","DOI":"10.1016\/j.celbio.2025.100148","author":"Z Huang","year":"2025","unstructured":"Huang Z, Li N, Gao Z, Chen J, Xue Z, Wu C, et al. Cuproptosis improves CAR-T cell therapy in osteosarcoma. Cell Biomater. 2025. https:\/\/doi.org\/10.1016\/j.celbio.2025.100148.","journal-title":"Cell Biomater"},{"issue":"3","key":"1831_CR258","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J Galon","year":"2019","unstructured":"Galon J, Bruni D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat Rev Drug Discov. 2019;18(3):197\u2013218.","journal-title":"Nat Rev Drug Discov"},{"issue":"7684","key":"1831_CR259","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature25016","volume":"552","author":"Z Skrott","year":"2017","unstructured":"Skrott Z, Mistrik M, Andersen KK, Friis S, Majera D, Gursky J, et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature. 2017;552(7684):194\u20139.","journal-title":"Nature"},{"issue":"5","key":"1831_CR260","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","volume":"21","author":"D Tang","year":"2024","unstructured":"Tang D, Kroemer G, Kang R. Targeting cuproplasia and cuproptosis in cancer. Nat Rev Clin Oncol. 2024;21(5):370\u201388.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"1831_CR261","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.ijrobp.2024.05.009","volume":"120","author":"J Huang","year":"2024","unstructured":"Huang J, Campian JL, DeWees TA, Skrott Z, Mistrik M, Johanns TM, et al. A phase 1\/2 study of disulfiram and copper with concurrent radiation therapy and temozolomide for patients with newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys. 2024;120(3):738\u201349.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1831_CR262","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11060-019-03125-y","volume":"142","author":"J Huang","year":"2019","unstructured":"Huang J, Chaudhary R, Cohen AL, Fink K, Goldlust S, Boockvar J, et al. A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma. J Neurooncol. 2019;142(3):537\u201344.","journal-title":"J Neurooncol"},{"issue":"3","key":"1831_CR263","doi-asserted-by":"publisher","first-page":"e234149","DOI":"10.1001\/jamanetworkopen.2023.4149","volume":"6","author":"K Werlenius","year":"2023","unstructured":"Werlenius K, Kinhult S, Solheim TS, Magelssen H, L\u00f6fgren D, Mudaisi M, et al. Effect of disulfiram and copper plus chemotherapy vs chemotherapy alone on survival in patients with recurrent glioblastoma: a randomized clinical trial. JAMA Netw Open. 2023;6(3):e234149.","journal-title":"JAMA Netw Open"},{"issue":"32","key":"1831_CR264","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1200\/JCO.2008.17.1579","volume":"27","author":"S O\u2019Day","year":"2009","unstructured":"O\u2019Day S, Gonzalez R, Lawson D, Weber R, Hutchins L, Anderson C, et al. Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma. J Clin Oncol. 2009;27(32):5452\u20138.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1831_CR265","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1200\/JCO.2012.44.5585","volume":"31","author":"SJ O\u2019Day","year":"2013","unstructured":"O\u2019Day SJ, Eggermont AM, Chiarion-Sileni V, Kefford R, Grob JJ, Mortier L, et al. Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma. J Clin Oncol. 2013;31(9):1211\u20138.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1831_CR266","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1158\/1078-0432.CCR-16-1326","volume":"23","author":"N Chan","year":"2017","unstructured":"Chan N, Willis A, Kornhauser N, Ward MM, Lee SB, Nackos E, et al. Influencing the tumor microenvironment: a phase II study of copper depletion using tetrathiomolybdate in patients with breast cancer at high risk for recurrence and in preclinical models of lung metastases. Clin Cancer Res. 2017;23(3):666\u201376.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1831_CR267","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/annonc\/mds654","volume":"24","author":"S Jain","year":"2013","unstructured":"Jain S, Cohen J, Ward MM, Kornhauser N, Chuang E, Cigler T, et al. Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse. Ann Oncol. 2013;24(6):1491\u20138.","journal-title":"Ann Oncol"},{"issue":"1","key":"1831_CR268","doi-asserted-by":"publisher","first-page":"29579","DOI":"10.1038\/s41598-024-81317-x","volume":"14","author":"J Liu","year":"2024","unstructured":"Liu J, Tang H, Chen F, Li C, Xie Y, Kang R, et al. NFE2L2 and SLC25A39 drive cuproptosis resistance through GSH metabolism. Sci Rep. 2024;14(1):29579.","journal-title":"Sci Rep"},{"issue":"1","key":"1831_CR269","first-page":"1","volume":"6","author":"GJ Brewer","year":"2000","unstructured":"Brewer GJ, Dick RD, Grover DK, LeClaire V, Tseng M, Wicha M, et al. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: phase I study. Clin Cancer Res. 2000;6(1):1\u201310.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1831_CR270","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13046-022-02485-0","volume":"41","author":"P Zheng","year":"2022","unstructured":"Zheng P, Zhou C, Lu L, Liu B, Ding Y. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. J Exp Clin Cancer Res. 2022;41(1):271.","journal-title":"J Exp Clin Cancer Res"},{"key":"1831_CR271","doi-asserted-by":"publisher","first-page":"963639","DOI":"10.3389\/fmolb.2023.963639","volume":"10","author":"W Huang","year":"2023","unstructured":"Huang W, Wu Y, Zhu J, Luo N, Wang C, Liu S, et al. Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas. Front Mol Biosci. 2023;10:963639.","journal-title":"Front Mol Biosci"},{"key":"1831_CR272","doi-asserted-by":"publisher","first-page":"994741","DOI":"10.3389\/fgene.2022.994741","volume":"13","author":"X Huang","year":"2022","unstructured":"Huang X, Wang T, Ye J, Feng H, Zhang X, Ma X, et al. FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis. Front Genet. 2022;13:994741.","journal-title":"Front Genet"},{"issue":"13","key":"1831_CR273","doi-asserted-by":"publisher","first-page":"6117","DOI":"10.18632\/aging.204807","volume":"15","author":"C Cai","year":"2023","unstructured":"Cai C, Zhou K, Jing J, Ren Y, Weng G, Cen D, et al. Confirmation of the predictive function of cuproptosis-related gene FDX1 in clear cell renal carcinoma using qRT-PCR and western blotting. Aging (Albany NY). 2023;15(13):6117\u201334.","journal-title":"Aging (Albany NY)"},{"key":"1831_CR274","first-page":"e18761429358008","volume":"17","author":"W Xu","year":"2024","unstructured":"Xu W, Liao S, Hu Y, Huang Y, Zhou J. Upregulation of miR-3130-5p enhances hepatocellular carcinoma growth by suppressing ferredoxin 1: miR-3130-5p enhances HCC growth via inhibiting FDX1. Curr Mol Pharmacol. 2024;17:e18761429358008.","journal-title":"Curr Mol Pharmacol"},{"issue":"26","key":"1831_CR275","doi-asserted-by":"publisher","first-page":"11775","DOI":"10.1073\/pnas.1004250107","volume":"107","author":"AD Sheftel","year":"2010","unstructured":"Sheftel AD, Stehling O, Pierik AJ, Els\u00e4sser HP, M\u00fchlenhoff U, Webert H, et al. Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe\/S cluster biosynthesis. Proc Natl Acad Sci U S A. 2010;107(26):11775\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1831_CR276","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41589-022-01159-4","volume":"19","author":"V Schulz","year":"2023","unstructured":"Schulz V, Basu S, Freibert SA, Webert H, Boss L, M\u00fchlenhoff U, et al. Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2. Nat Chem Biol. 2023;19(2):206\u201317.","journal-title":"Nat Chem Biol"},{"issue":"10","key":"1831_CR277","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.18632\/aging.204728","volume":"15","author":"L Xu","year":"2023","unstructured":"Xu L, Wu P, Rong A, Li K, Xiao X, Zhang Y, et al. Systematic pan-cancer analysis identifies cuproptosis-related gene DLAT as an immunological and prognostic biomarker. Aging (Albany NY). 2023;15(10):4269\u201387.","journal-title":"Aging (Albany NY)"},{"issue":"14","key":"1831_CR278","doi-asserted-by":"publisher","first-page":"e70012","DOI":"10.1002\/cam4.70012","volume":"13","author":"Y Peng","year":"2024","unstructured":"Peng Y, Shi R, Yang S, Zhu J. Cuproptosis-related gene DLAT is a biomarker of the prognosis and immune microenvironment of gastric cancer and affects the invasion and migration of cells. Cancer Med. 2024;13(14):e70012.","journal-title":"Cancer Med"},{"issue":"1","key":"1831_CR279","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1186\/s12885-023-11042-7","volume":"23","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhou Y, Hu J, Yu X, Xu H, Ba Z, et al. Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma. BMC Cancer. 2023;23(1):560.","journal-title":"BMC Cancer"},{"issue":"3","key":"1831_CR280","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.3390\/curroncol30030228","volume":"30","author":"Z Fang","year":"2023","unstructured":"Fang Z, Wang W, Liu Y, Hua J, Liang C, Liu J, et al. Cuproptosis-related gene DLAT as a novel biomarker correlated with prognosis, chemoresistance, and immune infiltration in pancreatic adenocarcinoma: a preliminary study based on bioinformatics analysis. Curr Oncol. 2023;30(3):2997\u20133019.","journal-title":"Curr Oncol"},{"issue":"8","key":"1831_CR281","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1007\/s12094-023-03118-4","volume":"25","author":"D Luo","year":"2023","unstructured":"Luo D, Liu S, Luo J, Chen H, He Z, Gao Z, et al. Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia. Clin Transl Oncol. 2023;25(8):2393\u2013407.","journal-title":"Clin Transl Oncol"},{"issue":"5","key":"1831_CR282","first-page":"2024","volume":"28","author":"X Yan","year":"2024","unstructured":"Yan X, Zheng W, Xu FS, Chang HL, Zhang Y, Zhang ZY, et al. Identification and validation of a novel cuproptosis signature for stratifying different prognostic, immune, metabolic, and therapeutic landscapes in pancreatic adenocarcinoma. Eur Rev Med Pharmacol Sci. 2024;28(5):2024\u201350.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"1831_CR283","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1080\/01635581.2020.1817957","volume":"73","author":"W Wang","year":"2021","unstructured":"Wang W, Wang X, Luo J, Chen X, Ma K, He H, et al. Serum copper level and the copper-to-zinc ratio could be useful in the prediction of lung cancer and its prognosis: a case-control study in Northeast China. Nutr Cancer. 2021;73(10):1908\u201315.","journal-title":"Nutr Cancer"},{"issue":"11","key":"1831_CR284","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1002\/ijc.31991","volume":"144","author":"AP Fang","year":"2019","unstructured":"Fang AP, Chen PY, Wang XY, Liu ZY, Zhang DM, Luo Y, et al. Serum copper and zinc levels at diagnosis and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort. Int J Cancer. 2019;144(11):2823\u201332.","journal-title":"Int J Cancer"},{"key":"1831_CR285","doi-asserted-by":"publisher","DOI":"10.3390\/nu16071000","author":"M Szwiec","year":"2024","unstructured":"Szwiec M, Marciniak W, Derkacz R, Huzarski T, Gronwald J, Cybulski C, et al. Serum levels of copper and zinc and survival in breast cancer patients. Nutrients. 2024. https:\/\/doi.org\/10.3390\/nu16071000.","journal-title":"Nutrients"},{"issue":"1","key":"1831_CR286","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1039\/C4MT00260A","volume":"7","author":"F Larner","year":"2015","unstructured":"Larner F, Woodley LN, Shousha S, Moyes A, Humphreys-Williams E, Strekopytov S, et al. Zinc isotopic compositions of breast cancer tissue. Metallomics. 2015;7(1):112\u20137.","journal-title":"Metallomics"},{"key":"1831_CR287","doi-asserted-by":"publisher","first-page":"126611","DOI":"10.1016\/j.jtemb.2020.126611","volume":"62","author":"B Toubhans","year":"2020","unstructured":"Toubhans B, Gourlan AT, Telouk P, Lutchman-Singh K, Francis LW, Conlan RS, et al. Cu isotope ratios are meaningful in ovarian cancer diagnosis. J Trace Elem Med Biol. 2020;62:126611.","journal-title":"J Trace Elem Med Biol"},{"issue":"3","key":"1831_CR288","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41423-026-01387-x","volume":"23","author":"Q Hao","year":"2026","unstructured":"Hao Q, Gan Y, Zhou X. Tackling cuproptosis: from metabolic rewiring to therapeutic exploitation in cancer. Cell Mol Immunol. 2026;23(3):239\u201360.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"1831_CR289","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1039\/c0cs00215a","volume":"40","author":"BM Paterson","year":"2011","unstructured":"Paterson BM, Donnelly PS. Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals. Chem Soc Rev. 2011;40(5):3005\u201318.","journal-title":"Chem Soc Rev"},{"issue":"7","key":"1831_CR290","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1021\/cb400198p","volume":"8","author":"MA Cater","year":"2013","unstructured":"Cater MA, Pearson HB, Wolyniec K, Klaver P, Bilandzic M, Paterson BM, et al. Increasing intracellular bioavailable copper selectively targets prostate cancer cells. ACS Chem Biol. 2013;8(7):1621\u201331.","journal-title":"ACS Chem Biol"},{"issue":"10","key":"1831_CR291","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.freeradbiomed.2012.03.017","volume":"52","author":"M Nagai","year":"2012","unstructured":"Nagai M, Vo NH, Shin Ogawa L, Chimmanamada D, Inoue T, Chu J, et al. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells. Free Radic Biol Med. 2012;52(10):2142\u201350.","journal-title":"Free Radic Biol Med"},{"issue":"27","key":"1831_CR292","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1038\/s41388-022-02364-0","volume":"41","author":"Y Li","year":"2022","unstructured":"Li Y, Yang J, Zhang Q, Xu S, Sun W, Ge S, et al. Copper ionophore elesclomol selectively targets GNAQ\/11-mutant uveal melanoma. Oncogene. 2022;41(27):3539\u201353.","journal-title":"Oncogene"},{"issue":"2","key":"1831_CR293","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10549-025-07663-0","volume":"211","author":"L Li","year":"2025","unstructured":"Li L, Zhang Z, Huang N, Ren J, Qin Y, Luo Y. IGF1R activates FOXP3-\u03b2-catenin signaling to promote breast cancer development. Breast Cancer Res Treat. 2025;211(2):467\u201378.","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"1831_CR294","doi-asserted-by":"publisher","first-page":"6160","DOI":"10.1016\/j.ymthe.2025.09.004","volume":"33","author":"Q Yu","year":"2025","unstructured":"Yu Q, Jiang K, Ma S, Zheng Q, Tondi S, Reina C, et al. Elesclomol-copper combination synergistically targets mitochondrial metabolism in cancer stem cells to overcome chemoresistance in PDAC. Mol Ther. 2025;33(12):6160\u201377.","journal-title":"Mol Ther"},{"issue":"20","key":"1831_CR295","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1158\/0008-5472.CAN-24-2558","volume":"85","author":"J Zhao","year":"2025","unstructured":"Zhao J, Zhang W, Zeng Y, Lu D, Ma C, Zhang M, et al. Targeting ATP7A-dependent copper metabolic homeostasis induces cuproptosis and suppresses the progression of mutant KRAS-driven lung cancer. Cancer Res. 2025;85(20):3999\u20134017.","journal-title":"Cancer Res"},{"key":"1831_CR296","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.freeradbiomed.2025.05.429","volume":"237","author":"L Yao","year":"2025","unstructured":"Yao L, Ye S, Xu D. UCHL3 augments cuproptosis via PKM2 deubiquitination in hepatocellular carcinoma. Free Radic Biol Med. 2025;237:65\u201375.","journal-title":"Free Radic Biol Med"},{"issue":"30","key":"1831_CR297","doi-asserted-by":"publisher","first-page":"e2401396","DOI":"10.1002\/advs.202401396","volume":"11","author":"X Gao","year":"2024","unstructured":"Gao X, Zhao H, Liu J, Wang M, Dai Z, Hao W, et al. Enzalutamide sensitizes castration-resistant prostate cancer to copper-mediated cell death. Adv Sci (Weinh). 2024;11(30):e2401396.","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"1831_CR298","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/s41418-023-01167-4","volume":"30","author":"DC Kanellis","year":"2023","unstructured":"Kanellis DC, Zisi A, Skrott Z, Lemmens B, Espinoza JA, Kosar M, et al. Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET. Cell Death Differ. 2023;30(7):1666\u201378.","journal-title":"Cell Death Differ"},{"issue":"21","key":"1831_CR299","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.1158\/0008-5472.CAN-06-2126","volume":"66","author":"D Chen","year":"2006","unstructured":"Chen D, Cui QC, Yang H, Dou QP. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res. 2006;66(21):10425\u201333.","journal-title":"Cancer Res"},{"issue":"3","key":"1831_CR300","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2174\/156800911794519806","volume":"11","author":"B Cvek","year":"2011","unstructured":"Cvek B. Targeting malignancies with disulfiram (Antabuse): multidrug resistance, angiogenesis, and proteasome. Curr Cancer Drug Targets. 2011;11(3):332\u20137.","journal-title":"Curr Cancer Drug Targets"},{"issue":"2","key":"1831_CR301","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/jb\/mvab045","volume":"170","author":"W Guo","year":"2021","unstructured":"Guo W, Zhang X, Lin L, Wang H, He E, Wang G, et al. The disulfiram\/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS\/JNK signalling pathway. J Biochem. 2021;170(2):275\u201387.","journal-title":"J Biochem"},{"issue":"5","key":"1831_CR302","doi-asserted-by":"publisher","first-page":"e2797","DOI":"10.1038\/cddis.2017.176","volume":"8","author":"B Xu","year":"2017","unstructured":"Xu B, Wang S, Li R, Chen K, He L, Deng M, et al. Disulfiram\/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-\u03baB and Nrf2. Cell Death Dis. 2017;8(5):e2797.","journal-title":"Cell Death Dis"},{"key":"1831_CR303","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-163","volume":"12","author":"J Zha","year":"2014","unstructured":"Zha J, Chen F, Dong H, Shi P, Yao Y, Zhang Y, et al. Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition. J Transl Med. 2014;12:163.","journal-title":"J Transl Med"},{"issue":"8","key":"1831_CR304","doi-asserted-by":"publisher","first-page":"186","DOI":"10.31083\/j.fbl2808186","volume":"28","author":"M Chu","year":"2023","unstructured":"Chu M, An X, Fu C, Yu H, Zhang D, Li Q, et al. Disulfiram\/copper induce ferroptosis in triple-negative breast cancer cell line MDA-MB-231. Front Biosci (Landmark Ed). 2023;28(8):186.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"6","key":"1831_CR305","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/sca.21332","volume":"38","author":"Y Yang","year":"2016","unstructured":"Yang Y, Zhang K, Wang Y, Li M, Sun X, Liang Z, et al. Disulfiram chelated with copper promotes apoptosis in human breast cancer cells by impairing the mitochondria functions. Scanning. 2016;38(6):825\u201336.","journal-title":"Scanning"},{"key":"1831_CR306","doi-asserted-by":"publisher","first-page":"176110","DOI":"10.1016\/j.ejphar.2023.176110","volume":"960","author":"X Ni","year":"2023","unstructured":"Ni X, Ye C, Yu X, Zhang Y, Hou Y, Zheng Q, et al. Overcoming the compensatory increase in NRF2 induced by NPL4 inhibition enhances disulfiram\/copper-induced oxidative stress and ferroptosis in renal cell carcinoma. Eur J Pharmacol. 2023;960:176110.","journal-title":"Eur J Pharmacol"},{"key":"1831_CR307","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27020980","author":"E Wang","year":"2026","unstructured":"Wang E, Zhang Y, Jia L, Lin Z, Sun T, Hu P, et al. Disulfiram\/copper combined with irradiation induces immunogenic cell death in melanoma. Int J Mol Sci. 2026. https:\/\/doi.org\/10.3390\/ijms27020980.","journal-title":"Int J Mol Sci"},{"key":"1831_CR308","doi-asserted-by":"publisher","first-page":"103007","DOI":"10.1016\/j.redox.2023.103007","volume":"69","author":"P Zhang","year":"2024","unstructured":"Zhang P, Zhou C, Ren X, Jing Q, Gao Y, Yang C, et al. Inhibiting the compensatory elevation of xCT collaborates with disulfiram\/copper-induced GSH consumption for cascade ferroptosis and cuproptosis. Redox Biol. 2024;69:103007.","journal-title":"Redox Biol"},{"issue":"3","key":"1831_CR309","doi-asserted-by":"publisher","first-page":"333","DOI":"10.32604\/or.2023.028694","volume":"31","author":"Y Gan","year":"2023","unstructured":"Gan Y, Liu T, Feng W, Wang L, Li LI, Ning Y. Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways. Oncol Res. 2023;31(3):333\u201343.","journal-title":"Oncol Res"},{"issue":"6","key":"1831_CR310","doi-asserted-by":"publisher","first-page":"R897","DOI":"10.1186\/bcr1322","volume":"7","author":"KG Daniel","year":"2005","unstructured":"Daniel KG, Chen D, Orlu S, Cui QC, Miller FR, Dou QP. Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells. Breast Cancer Res. 2005;7(6):R897-908.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1831_CR311","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1042\/BJ20081421","volume":"417","author":"H Yu","year":"2009","unstructured":"Yu H, Zhou Y, Lind SE, Ding WQ. Clioquinol targets zinc to lysosomes in human cancer cells. Biochem J. 2009;417(1):133\u20139.","journal-title":"Biochem J"},{"issue":"2","key":"1831_CR312","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1042\/BJ20110123","volume":"436","author":"MA Cater","year":"2011","unstructured":"Cater MA, Haupt Y. Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer. Biochem J. 2011;436(2):481\u201391.","journal-title":"Biochem J"},{"issue":"4","key":"1831_CR313","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/17425247.2023.2190581","volume":"20","author":"BM Benk\u0151","year":"2023","unstructured":"Benk\u0151 BM, Lamprou DA, Sebesty\u00e9n A, Zelk\u00f3 R, Sebe I. Clinical, pharmacological, and formulation evaluation of disulfiram in the treatment of glioblastoma - a systematic literature review. Expert Opin Drug Deliv. 2023;20(4):541\u201357.","journal-title":"Expert Opin Drug Deliv"},{"issue":"5","key":"1831_CR314","doi-asserted-by":"publisher","first-page":"115441","DOI":"10.1016\/j.isci.2026.115441","volume":"29","author":"BM Benk\u0151","year":"2026","unstructured":"Benk\u0151 BM, De Brito Parreirinha NS, Sebe I, Zelk\u00f3 R. Off-label and repurposed use of disulfiram beyond alcohol dependence: a systematic review of clinical and preclinical evidence. iScience. 2026;29(5):115441.","journal-title":"iScience"},{"issue":"1","key":"1831_CR315","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11095-025-03964-7","volume":"43","author":"P Desai","year":"2026","unstructured":"Desai P, Bang K, Chowdhury MRH, Wang ZK, Wang J, Prabhu S, et al. Development, optimization, and evaluation of nano self-emulsifying drug delivery system formulation platform for oral bioavailability enhancement of sulfasalazine and disulfiram in lung cancer chemoprevention. Pharm Res. 2026;43(1):195\u2013215.","journal-title":"Pharm Res"},{"key":"1831_CR316","doi-asserted-by":"publisher","first-page":"113615","DOI":"10.1016\/j.jconrel.2025.113615","volume":"381","author":"I Gonzalez-Prada","year":"2025","unstructured":"Gonzalez-Prada I, Barcelos Ribeiro A, Dion M, Magari\u00f1os B, Lapoujade C, Rousseau A, et al. Disulfiram-loaded electrospun fibers with antimicrobial and antitumoral properties for glioblastoma treatment. J Control Release. 2025;381:113615.","journal-title":"J Control Release"},{"issue":"1","key":"1831_CR317","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13045-024-01589-8","volume":"17","author":"C Zhang","year":"2024","unstructured":"Zhang C, Huang T, Li L. Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives. J Hematol Oncol. 2024;17(1):68.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1831_CR318","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12920-023-01511-0","volume":"16","author":"D Zhang","year":"2023","unstructured":"Zhang D, Lu W, Zhuo Z, Wang Y, Zhang W, Zhang M. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer. BMC Med Genomics. 2023;16(1):96.","journal-title":"BMC Med Genomics"},{"issue":"1","key":"1831_CR319","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12885-023-10714-8","volume":"23","author":"M Zhang","year":"2023","unstructured":"Zhang M, Liu X, Wang D, Ruan X, Wang P, Liu L, et al. A novel cuproptosis-related gene signature to predict prognosis in Glioma. BMC Cancer. 2023;23(1):237.","journal-title":"BMC Cancer"},{"issue":"3","key":"1831_CR320","doi-asserted-by":"publisher","first-page":"E41","DOI":"10.1002\/hep.32801","volume":"82","author":"ML Schilsky","year":"2025","unstructured":"Schilsky ML, Roberts EA, Bronstein JM, Dhawan A, Hamilton JP, Rivard AM, et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 practice guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology. 2025;82(3):E41\u201390.","journal-title":"Hepatology"},{"key":"1831_CR321","doi-asserted-by":"publisher","first-page":"103846","DOI":"10.1016\/j.redox.2025.103846","volume":"86","author":"Y Wu","year":"2025","unstructured":"Wu Y, Alotaibi KS, Yu K, Durham T, Dal-Pizzol F, Singer M, et al. Mechanisms, therapeutic uses, and developmental perspectives of redox-active thiomolybdates. Redox Biol. 2025;86:103846.","journal-title":"Redox Biol"},{"issue":"1","key":"1831_CR322","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41523-021-00313-w","volume":"7","author":"YL Liu","year":"2021","unstructured":"Liu YL, Bager CL, Willumsen N, Ramchandani D, Kornhauser N, Ling L, et al. Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer. NPJ Breast Cancer. 2021;7(1):108.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"1831_CR323","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13046-023-02663-8","volume":"42","author":"JL Hancock","year":"2023","unstructured":"Hancock JL, Kalimutho M, Straube J, Lim M, Gresshoff I, Saunus JM, et al. COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis. J Exp Clin Cancer Res. 2023;42(1):90.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"1831_CR324","doi-asserted-by":"publisher","first-page":"786","DOI":"10.2174\/1871520622666220907115027","volume":"23","author":"L Nan","year":"2023","unstructured":"Nan L, Yuan W, Guodong C, Yonghui H. Multitargeting strategy using tetrathiomolybdate and lenvatinib: maximizing antiangiogenesis activity in a preclinical liver cancer model. Anticancer Agents Med Chem. 2023;23(7):786\u201393.","journal-title":"Anticancer Agents Med Chem"},{"issue":"7755","key":"1831_CR325","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0140-6736(72)90845-8","volume":"1","author":"HB Dixon","year":"1972","unstructured":"Dixon HB, Gibbs K, Walshe JM. Preparation of triethylenetetramine dihydrochloride for the treatment of Wilson\u2019s disease. Lancet. 1972;1(7755):853.","journal-title":"Lancet"},{"issue":"22","key":"1831_CR326","doi-asserted-by":"publisher","first-page":"7526","DOI":"10.1158\/1078-0432.CCR-08-0315","volume":"14","author":"SA Lowndes","year":"2008","unstructured":"Lowndes SA, Adams A, Timms A, Fisher N, Smythe J, Watt SM, et al. Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumors. Clin Cancer Res. 2008;14(22):7526\u201334.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1831_CR327","first-page":"e66765","volume":"16","author":"G Singh","year":"2024","unstructured":"Singh G, Goswami K, Farooq A, Trehan S, Arora RS, Bector G, et al. Copper deficiency mimicking myelodysplastic syndrome: a case report. Cureus. 2024;16(8):e66765.","journal-title":"Cureus"},{"key":"1831_CR328","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121887","author":"S Blockhuys","year":"2021","unstructured":"Blockhuys S, Hildesj\u00f6 C, Olsson H, Vahdat L, Wittung-Stafshede P. Evaluation of ATOX1 as a potential predictive biomarker for tetrathiomolybdate treatment of breast cancer patients with high risk of recurrence. Biomedicines. 2021. https:\/\/doi.org\/10.3390\/biomedicines9121887.","journal-title":"Biomedicines"},{"issue":"3","key":"1831_CR329","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1021\/acs.molpharmaceut.5c01708","volume":"23","author":"SX Zhang","year":"2026","unstructured":"Zhang SX, Li LG, Wang LJ, Chen NN, Leng F, Xu HZ, et al. Deciphering copper homeostasis and cuproptosis: biological mechanisms, disease connections, and cutting-edge copper-based nanomedicine. Mol Pharm. 2026;23(3):1463\u201395.","journal-title":"Mol Pharm"},{"issue":"57","key":"1831_CR330","doi-asserted-by":"publisher","first-page":"49643","DOI":"10.1039\/D5RA07735D","volume":"15","author":"H Zhang","year":"2025","unstructured":"Zhang H, Ding B, Kou Q. Functional nano-nucleic acid platform promotes copper-induced gastric cancer cell death. RSC Adv. 2025;15(57):49643\u201351.","journal-title":"RSC Adv"},{"key":"1831_CR331","doi-asserted-by":"publisher","first-page":"123626","DOI":"10.1016\/j.biomaterials.2025.123626","volume":"325","author":"X Zhan","year":"2026","unstructured":"Zhan X, Xiao H, Zhang X, Li S, Zhang W, Ma L, et al. A metallic metabolic nano-regulator reprograms the PKM2\/HIF-1\u03b1\/DLAT axis to amplify tumor-specific cuproptosis. Biomaterials. 2026;325:123626.","journal-title":"Biomaterials"},{"issue":"41","key":"1831_CR332","doi-asserted-by":"publisher","first-page":"36701","DOI":"10.1021\/acsnano.5c12641","volume":"19","author":"W Zhang","year":"2025","unstructured":"Zhang W, Feng ZY, Feng Z, Lian R, Liu Z, Zhang J. A CRISPR-customizable copper-coordinated DNA nanoplatform potentiates cuproptosis through circadian and metabolic pathway manipulation. ACS Nano. 2025;19(41):36701\u201317.","journal-title":"ACS Nano"},{"key":"1831_CR333","doi-asserted-by":"publisher","first-page":"218155","DOI":"10.1016\/j.canlet.2025.218155","volume":"638","author":"G Li","year":"2026","unstructured":"Li G, Wan Y, Cui G, Jiang K, Su J, Duan S, et al. Cancer metastasis mediated by circadian rhythm disruption: molecular mechanisms to clinical significance and implications. Cancer Lett. 2026;638:218155.","journal-title":"Cancer Lett"},{"issue":"9","key":"1831_CR334","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1016\/j.apsb.2024.05.029","volume":"14","author":"X Wu","year":"2024","unstructured":"Wu X, Bai Z, Wang H, Wang H, Hou D, Xu Y, et al. CRISPR-Cas9 gene editing strengthens cuproptosis\/chemodynamic\/ferroptosis synergistic cancer therapy. Acta Pharm Sin B. 2024;14(9):4059\u201372.","journal-title":"Acta Pharm Sin B"},{"key":"1831_CR335","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.actbio.2024.05.035","volume":"183","author":"H Huang","year":"2024","unstructured":"Huang H, Guo H, Liu J, Ni C, Xia L, Cao X, et al. Dendrimer\/metal-phenolic nanocomplexes encapsulating CuO(2) for targeted magnetic resonance imaging and enhanced ferroptosis\/cuproptosis\/chemodynamic therapy by regulating the tumor microenvironment. Acta Biomater. 2024;183:252\u201363.","journal-title":"Acta Biomater"},{"issue":"36","key":"1831_CR336","doi-asserted-by":"publisher","first-page":"e17616","DOI":"10.1002\/advs.202417616","volume":"12","author":"C Liu","year":"2025","unstructured":"Liu C, Guo L, Cheng Y, Gao J, Pan H, Zhu J, et al. A mitochondria-targeted nanozyme platform for multi-pathway tumor therapy via ferroptosis and cuproptosis regulation. Adv Sci (Weinh). 2025;12(36):e17616.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"1831_CR337","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12951-025-03220-5","volume":"23","author":"Y Qian","year":"2025","unstructured":"Qian Y, Wang C, Xu R, Wang J, Chen Q, Zhu Z, et al. Copper-based metal-organic frameworks for antitumor application. J Nanobiotechnol. 2025;23(1):135.","journal-title":"J Nanobiotechnol"},{"issue":"15","key":"1831_CR338","doi-asserted-by":"publisher","first-page":"eadk3201","DOI":"10.1126\/sciadv.adk3201","volume":"10","author":"K Chen","year":"2024","unstructured":"Chen K, Zhou A, Zhou X, He J, Xu Y, Ning X. Cellular Trojan horse initiates bimetallic Fe-Cu MOF-mediated synergistic cuproptosis and ferroptosis against malignancies. Sci Adv. 2024;10(15):eadk3201.","journal-title":"Sci Adv"},{"issue":"38","key":"1831_CR339","doi-asserted-by":"publisher","first-page":"2300941","DOI":"10.1002\/adfm.202300941","volume":"33","author":"F Zhao","year":"2023","unstructured":"Zhao F, Liang L, Wang H, Wang C, Su D, Ying Y, et al. H2S-activated ion-interference therapy: a novel tumor targeted therapy based on copper-overload-mediated cuproptosis and pyroptosis. Adv Funct Mater. 2023;33(38):2300941.","journal-title":"Adv Funct Mater"},{"issue":"43","key":"1831_CR340","doi-asserted-by":"publisher","first-page":"30053","DOI":"10.1021\/acsnano.4c11455","volume":"18","author":"W Xu","year":"2024","unstructured":"Xu W, Suo A, Aldai AJM, Wang Y, Fan J, Xia Y, et al. Hollow calcium\/copper bimetallic amplifier for cuproptosis\/paraptosis\/apoptosis cancer therapy via cascade reinforcement of endoplasmic reticulum stress and mitochondrial dysfunction. ACS Nano. 2024;18(43):30053\u201368.","journal-title":"ACS Nano"},{"issue":"11","key":"1831_CR341","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1016\/j.drudis.2021.06.011","volume":"26","author":"B Szabat-Iriaka","year":"2021","unstructured":"Szabat-Iriaka B, Le Borgne M. Brain safety concerns of nanomedicines: the need for a specific regulatory framework. Drug Discov Today. 2021;26(11):2502\u20137.","journal-title":"Drug Discov Today"},{"issue":"1","key":"1831_CR342","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","volume":"15","author":"IV Zelepukin","year":"2024","unstructured":"Zelepukin IV, Shevchenko KG, Deyev SM. Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery. Nat Commun. 2024;15(1):4366.","journal-title":"Nat Commun"},{"key":"1831_CR343","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210082","author":"J Kim","year":"2023","unstructured":"Kim J, Cho H, Lim DK, Joo MK, Kim K. Perspectives for improving the tumor targeting of nanomedicine via the EPR effect in clinical tumors. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241210082.","journal-title":"Int J Mol Sci"},{"key":"1831_CR344","doi-asserted-by":"publisher","first-page":"214636","DOI":"10.1016\/j.bioadv.2025.214636","volume":"181","author":"MS Khan","year":"2026","unstructured":"Khan MS, Alqahtani T, Al Shmrany H, Gupta G, Goh KW, Sahebkar A, et al. Enhanced permeability and retention (EPR) effect: advances in nanomedicine for improved tumor targeting. Biomater Adv. 2026;181:214636.","journal-title":"Biomater Adv"},{"issue":"13","key":"1831_CR345","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.7150\/thno.57828","volume":"11","author":"G Wei","year":"2021","unstructured":"Wei G, Wang Y, Yang G, Wang Y, Ju R. Recent progress in nanomedicine for enhanced cancer chemotherapy. Theranostics. 2021;11(13):6370\u201392.","journal-title":"Theranostics"},{"issue":"10","key":"1831_CR346","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41571-025-01059-1","volume":"22","author":"M Ge","year":"2025","unstructured":"Ge M, Chen XY, Huang P, Fleishman JS, Yang DH, Wu ZX, et al. Understanding and overcoming multidrug resistance in cancer. Nat Rev Clin Oncol. 2025;22(10):760\u201380.","journal-title":"Nat Rev Clin Oncol"},{"key":"1831_CR347","doi-asserted-by":"publisher","first-page":"1055356","DOI":"10.3389\/fmolb.2022.1055356","volume":"9","author":"A Schoeberl","year":"2022","unstructured":"Schoeberl A, Gutmann M, Theiner S, Corte-Rodr\u00edguez M, Braun G, Vician P, et al. The copper transporter CTR1 and cisplatin accumulation at the single-cell level by LA-ICP-TOFMS. Front Mol Biosci. 2022;9:1055356.","journal-title":"Front Mol Biosci"},{"issue":"4","key":"1831_CR348","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1124\/mol.104.001198","volume":"66","author":"AK Holzer","year":"2004","unstructured":"Holzer AK, Samimi G, Katano K, Naerdemann W, Lin X, Safaei R, et al. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells. Mol Pharmacol. 2004;66(4):817\u201323.","journal-title":"Mol Pharmacol"},{"issue":"4","key":"1831_CR349","doi-asserted-by":"publisher","first-page":"e0125402","DOI":"10.1371\/journal.pone.0125402","volume":"10","author":"X Wang","year":"2015","unstructured":"Wang X, Jiang P, Wang P, Yang CS, Wang X, Feng Q. EGCG enhances cisplatin sensitivity by regulating expression of the copper and cisplatin influx transporter CTR1 in ovary cancer. PLoS ONE. 2015;10(4):e0125402.","journal-title":"PLoS ONE"},{"key":"1831_CR350","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.ijbiomac.2020.07.241","volume":"161","author":"A Pandit","year":"2020","unstructured":"Pandit A, Khare L, Jahagirdar D, Srivastav A, Jain R, Dandekar P. Probing synergistic interplay between bio-inspired peptidomimetic chitosan-copper complexes and doxorubicin. Int J Biol Macromol. 2020;161:1475\u201383.","journal-title":"Int J Biol Macromol"},{"issue":"28","key":"1831_CR351","doi-asserted-by":"publisher","first-page":"e2401646","DOI":"10.1002\/adhm.202401646","volume":"13","author":"N Wang","year":"2024","unstructured":"Wang N, Liu Y, Peng D, Zhang Q, Zhang Z, Xu L, et al. Copper-based composites nanoparticles improve triple-negative breast cancer treatment with induction of apoptosis-cuproptosis and immune activation. Adv Healthc Mater. 2024;13(28):e2401646.","journal-title":"Adv Healthc Mater"},{"issue":"2","key":"1831_CR352","first-page":"101010","volume":"20","author":"Y Ding","year":"2025","unstructured":"Ding Y, Chen R, Zhou J, Bao Y, Meng N, Zheng X, et al. All-stage targeted nanodiscs for glioma treatment by inducing cuproptosis and apoptosis of cancer cells and cancer stem cells. Asian J Pharm Sci. 2025;20(2):101010.","journal-title":"Asian J Pharm Sci"},{"key":"1831_CR353","doi-asserted-by":"publisher","first-page":"101707","DOI":"10.1016\/j.mtbio.2025.101707","volume":"32","author":"Y Huang","year":"2025","unstructured":"Huang Y, Tian H, Yue Z, Liang L, Huang C, Zhu H, et al. Copper-coordination driven nano-frameworks for efficient colorectal cancer chemo-immunotherapy by suppression of cancer cell stemness. Mater Today Bio. 2025;32:101707.","journal-title":"Mater Today Bio"},{"key":"1831_CR354","doi-asserted-by":"publisher","first-page":"123201","DOI":"10.1016\/j.carbpol.2024.123201","volume":"352","author":"J Qian","year":"2025","unstructured":"Qian J, Aldai AJM, Xu W, Wang T, Zhao K, Wang Y, et al. Hyaluronan-decorated CuO(2)-doxorubicin nanodot clusters for targetedly sensitizing cuproptosis in breast cancer via a three-pronged strategy. Carbohydr Polym. 2025;352:123201.","journal-title":"Carbohydr Polym"},{"issue":"13","key":"1831_CR355","doi-asserted-by":"publisher","first-page":"12383","DOI":"10.1021\/acsnano.3c01792","volume":"17","author":"D Hao","year":"2023","unstructured":"Hao D, Meng Q, Li C, Lu S, Xiang X, Pei Q, et al. A Paclitaxel prodrug with copper depletion for combined therapy toward triple-negative breast cancer. ACS Nano. 2023;17(13):12383\u201393.","journal-title":"ACS Nano"},{"key":"1831_CR356","doi-asserted-by":"publisher","first-page":"117415","DOI":"10.1016\/j.biopha.2024.117415","volume":"179","author":"Y Jin","year":"2024","unstructured":"Jin Y, Wu Q, Pan S, Zhou Q, Liu H, Zhang Q, et al. Baicalein enhances cisplatin sensitivity in cervical cancer cells by promoting cuproptosis through the Akt pathway. Biomed Pharmacother. 2024;179:117415.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"1831_CR357","doi-asserted-by":"publisher","first-page":"e0291981","DOI":"10.1371\/journal.pone.0291981","volume":"18","author":"Z Lafi","year":"2023","unstructured":"Lafi Z, Alshaer W, Gharaibeh L, Alqudah DA, AlQuaissi B, Bashaireh B, et al. Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line. PLoS ONE. 2023;18(9):e0291981.","journal-title":"PLoS ONE"},{"issue":"6","key":"1831_CR358","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s43440-020-00122-1","volume":"72","author":"KL Swetha","year":"2020","unstructured":"Swetha KL, Sharma S, Chowdhury R, Roy A. Disulfiram potentiates docetaxel cytotoxicity in breast cancer cells through enhanced ROS and autophagy. Pharmacol Rep. 2020;72(6):1749\u201365.","journal-title":"Pharmacol Rep"},{"key":"1831_CR359","doi-asserted-by":"publisher","first-page":"115498","DOI":"10.1016\/j.bcp.2023.115498","volume":"211","author":"XX Yuan","year":"2023","unstructured":"Yuan XX, Duan YF, Luo C, Li L, Yang MJ, Liu TY, et al. Disulfiram enhances cisplatin cytotoxicity by forming a novel platinum chelate Pt(DDTC)(3)(). Biochem Pharmacol. 2023;211:115498.","journal-title":"Biochem Pharmacol"},{"key":"1831_CR360","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canlet.2020.05.006","volume":"486","author":"A Jangra","year":"2020","unstructured":"Jangra A, Choi SA, Yang J, Koh EJ, Phi JH, Lee JY, et al. Disulfiram potentiates the anticancer effect of cisplatin in atypical teratoid\/rhabdoid tumors (AT\/RT). Cancer Lett. 2020;486:38\u201345.","journal-title":"Cancer Lett"},{"key":"1831_CR361","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jconrel.2023.02.023","volume":"356","author":"KL Swetha","year":"2023","unstructured":"Swetha KL, Paul M, Maravajjala KS, Kumbham S, Biswas S, Roy A. Overcoming drug resistance with a docetaxel and disulfiram loaded pH-sensitive nanoparticle. J Control Release. 2023;356:93\u2013114.","journal-title":"J Control Release"},{"issue":"2","key":"1831_CR362","doi-asserted-by":"publisher","first-page":"e2205354","DOI":"10.1002\/smll.202205354","volume":"19","author":"W Jia","year":"2023","unstructured":"Jia W, Tian H, Jiang J, Zhou L, Li L, Luo M, et al. Brain-targeted HFn-Cu-REGO nanoplatform for site-specific delivery and manipulation of autophagy and cuproptosis in glioblastoma. Small. 2023;19(2):e2205354.","journal-title":"Small"},{"issue":"1","key":"1831_CR363","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13046-026-03642-5","volume":"45","author":"H Yang","year":"2026","unstructured":"Yang H, Xiong X, Chen X, Huang S, Dai H, Yuan L, et al. A mitochondrion-targeted natural polyphenolic copper carrier overcomes tumor resistance to cisplatin by potentiating cuproptosis. J Exp Clin Cancer Res. 2026;45(1):53.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"1831_CR364","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1016\/j.apsb.2024.08.014","volume":"14","author":"J Zou","year":"2024","unstructured":"Zou J, Xing X, Teng C, Zhao Q, He W, Wu X, et al. Cocrystal@protein-anchoring nanococktail for combinatorially treating multidrug-resistant cancer. Acta Pharm Sin B. 2024;14(10):4509\u201325.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"1831_CR365","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12943-023-01839-2","volume":"22","author":"L An","year":"2023","unstructured":"An L, Li M, Jia Q. Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma. Mol Cancer. 2023;22(1):140.","journal-title":"Mol Cancer"},{"issue":"6","key":"1831_CR366","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.ccell.2025.03.031","volume":"43","author":"G Lei","year":"2025","unstructured":"Lei G, Sun M, Cheng J, Ye R, Lu Z, Horbath A, et al. Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance. Cancer Cell. 2025;43(6):1076-1092.e1075.","journal-title":"Cancer Cell"},{"issue":"1","key":"1831_CR367","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s10388-022-00948-z","volume":"20","author":"L Qian","year":"2023","unstructured":"Qian L, Murakami K, Toyozumi T, Matsumoto Y, Otsuka R, Sekino N, et al. An anti-alcoholism drug, disulfiram and copper complex improves radio-resistance of tumor-initiating cells in esophageal squamous cell carcinoma. Esophagus. 2023;20(1):134\u201342.","journal-title":"Esophagus"},{"issue":"1","key":"1831_CR368","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40164-025-00653-4","volume":"14","author":"W Jing","year":"2025","unstructured":"Jing W, Wang W, Ding Y, Zeng R, Zhu H, Kang Z, et al. GLS2 inhibition synergizes with copper to reprogram TCA cycle for cuproptosis-driven radiosensitization in esophageal cancer. Exp Hematol Oncol. 2025;14(1):55.","journal-title":"Exp Hematol Oncol"},{"issue":"12","key":"1831_CR369","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41565-024-01784-1","volume":"19","author":"Y Liao","year":"2024","unstructured":"Liao Y, Wang D, Gu C, Wang X, Zhu S, Zheng Z, et al. A cuproptosis nanocapsule for cancer radiotherapy. Nat Nanotechnol. 2024;19(12):1892\u2013902.","journal-title":"Nat Nanotechnol"},{"issue":"5","key":"1831_CR370","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1021\/acsnano.4c13753","volume":"19","author":"T Jiang","year":"2025","unstructured":"Jiang T, Jia T, Yin Y, Li T, Song X, Feng W, et al. Cuproptosis-inducing functional nanocomposites for enhanced and synergistic cancer radiotherapy. ACS Nano. 2025;19(5):5429\u201346.","journal-title":"ACS Nano"},{"key":"1831_CR371","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.2147\/IJN.S504148","volume":"20","author":"L Xin","year":"2025","unstructured":"Xin L, Ning S, Wang H, Shi R. Tumor microenvironment responsive and platelet membrane coated polydopamine nanoparticles for cancer radiosensitization by inducing cuproptosis. Int J Nanomedicine. 2025;20:3643\u201352.","journal-title":"Int J Nanomedicine"},{"issue":"5","key":"1831_CR372","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1667\/RADE-24-00046.1","volume":"202","author":"Q Lian","year":"2024","unstructured":"Lian Q, Chen F, Sha Z, Zhao H, Li J, Chen T, et al. Disulfiram upgrades the radiosensitivity of osteosarcoma by enhancing apoptosis and P53-induced cell cycle arrest. Radiat Res. 2024;202(5):752\u201364.","journal-title":"Radiat Res"},{"issue":"19","key":"1831_CR373","doi-asserted-by":"publisher","first-page":"e70611","DOI":"10.1111\/jcmm.70611","volume":"29","author":"C Chen","year":"2025","unstructured":"Chen C, Peng M, Liang S, Li C, Zhu L, Yang Y, et al. Copper homeostasis, emerging central players in cancer immunotherapy. J Cell Mol Med. 2025;29(19):e70611.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1831_CR374","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12672-023-00729-9","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, Zong Y, Chen L, Li Q, Li Z, Meng R. The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics. Discov Oncol. 2023;14(1):103.","journal-title":"Discov Oncol"},{"issue":"18","key":"1831_CR375","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309984","volume":"11","author":"X Lu","year":"2024","unstructured":"Lu X, Chen X, Lin C, Yi Y, Zhao S, Zhu B, et al. Elesclomol loaded copper oxide nanoplatform triggers cuproptosis to enhance antitumor immunotherapy. Adv Sci. 2024;11(18):e2309984.","journal-title":"Adv Sci"},{"issue":"22","key":"1831_CR376","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202212267","volume":"35","author":"B Guo","year":"2023","unstructured":"Guo B, Yang F, Zhang L, Zhao Q, Wang W, Yin L, et al. Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy. Adv Mater. 2023;35(22):e2212267.","journal-title":"Adv Mater"},{"issue":"1","key":"1831_CR377","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-025-03409-4","volume":"44","author":"P Wang","year":"2025","unstructured":"Wang P, Guo W, Liu S, Li S, Li J, Ding B, et al. Novel Pt@PCN-Cu-induced cuproptosis amplifies \u03b1PD-L1 immunotherapy in pancreatic ductal adenocarcinoma through mitochondrial HK2-mediated PD-L1 upregulation. J Exp Clin Cancer Res. 2025;44(1):149.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1831_CR378","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12951-025-03924-8","volume":"24","author":"B Weng","year":"2026","unstructured":"Weng B, Zhu N, Li H, Ding L, Wu Y, Chen Y, et al. Reinvigorating CD8(+) T cells through ADRB1 blockade using copper-propranolol nanoparticles for enhanced immune checkpoint blockade therapy. J Nanobiotechnol. 2026;24(1):24.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"1831_CR379","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1021\/jacs.3c08622","volume":"146","author":"Y Liu","year":"2024","unstructured":"Liu Y, Niu R, Zhao H, Wang Y, Song S, Zhang H, et al. Single-site nanozymes with a highly conjugated coordination structure for antitumor immunotherapy via cuproptosis and cascade-enhanced T lymphocyte activity. J Am Chem Soc. 2024;146(6):3675\u201388.","journal-title":"J Am Chem Soc"},{"key":"1831_CR380","doi-asserted-by":"publisher","first-page":"102209","DOI":"10.1016\/j.mtbio.2025.102209","volume":"34","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Yuan J, Qi Y, Sun M, Zhang Y, Zhang G, et al. Dual molecularly imprinted nanocomposite with transferrin mediated glioma targeting and cholesterol exhaustion for synergistic cuproptosis\/immune checkpoint blockade\/immunogenic cell death. Mater Today Bio. 2025;34:102209.","journal-title":"Mater Today Bio"},{"issue":"1","key":"1831_CR381","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12951-025-03284-3","volume":"23","author":"L Gu","year":"2025","unstructured":"Gu L, Sun Y, Bai T, Shao S, Tang S, Xue P, et al. Functional nanozyme system for synergistic tumor immunotherapy via cuproptosis and ferroptosis activation. J Nanobiotechnol. 2025;23(1):212.","journal-title":"J Nanobiotechnol"},{"issue":"30","key":"1831_CR382","doi-asserted-by":"publisher","first-page":"27902","DOI":"10.1021\/acsnano.5c09491","volume":"19","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Zhang W, Liu L, Wu Y, Li W, Liang J, et al. Gelatin methacryloyl xerogel puncture implants loaded with Cu(0.5)Mn(2.5)O(4) nanoparticles synergizes cuproptosis and STING activation for enhanced breast cancer immunotherapy. ACS Nano. 2025;19(30):27902\u201318.","journal-title":"ACS Nano"},{"issue":"28","key":"1831_CR383","doi-asserted-by":"publisher","first-page":"e2400204","DOI":"10.1002\/adhm.202400204","volume":"13","author":"X Xu","year":"2024","unstructured":"Xu X, Li H, Tong B, Zhang W, Wang X, Wang Y, et al. Biomimetic nano-regulator that induces cuproptosis and lactate-depletion mediated ROS storm for metalloimmunotherapy of clear cell renal cell carcinoma. Adv Healthc Mater. 2024;13(28):e2400204.","journal-title":"Adv Healthc Mater"},{"issue":"Pt 2","key":"1831_CR384","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2025.138301","volume":"699","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Wang N, Zhang H, Ling J, Omer AM, Yang G, et al. Copper peroxide-triggered reactive nitrogen effectively enhanced synergistic chemodynamic-immunotherapy. J Colloid Interface Sci. 2025;699(Pt 2):138301.","journal-title":"J Colloid Interface Sci"},{"issue":"1","key":"1831_CR385","doi-asserted-by":"publisher","first-page":"10060","DOI":"10.1038\/s41467-024-54469-7","volume":"15","author":"M Guan","year":"2024","unstructured":"Guan M, Cheng K, Xie XT, Li Y, Ma MW, Zhang B, et al. Regulating copper homeostasis of tumor cells to promote cuproptosis for enhancing breast cancer immunotherapy. Nat Commun. 2024;15(1):10060.","journal-title":"Nat Commun"},{"issue":"Pt 1","key":"1831_CR386","doi-asserted-by":"publisher","first-page":"138100","DOI":"10.1016\/j.jcis.2025.138100","volume":"699","author":"J Xu","year":"2025","unstructured":"Xu J, Wang Y, Williams GR, Zheng Y, Zhang Y, Wang T, et al. A photothermally triggered cascade bioreactor for cuproptosis and ferroptosis-driven cancer immunotherapy. J Colloid Interface Sci. 2025;699(Pt 1):138100.","journal-title":"J Colloid Interface Sci"},{"key":"1831_CR387","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jconrel.2023.08.055","volume":"362","author":"T Liu","year":"2023","unstructured":"Liu T, Zhou Z, Zhang M, Lang P, Li J, Liu Z, et al. Cuproptosis-immunotherapy using PD-1 overexpressing T cell membrane-coated nanosheets efficiently treats tumor. J Control Release. 2023;362:502\u201312.","journal-title":"J Control Release"},{"key":"1831_CR388","doi-asserted-by":"publisher","first-page":"218281","DOI":"10.1016\/j.canlet.2026.218281","volume":"641","author":"D Heroux","year":"2026","unstructured":"Heroux D, Sun XX, Zhang S, Sharifiaghdam M, Leung AW, Farzaneh S, et al. Copper ionophores drive divergent responses to immune checkpoint inhibition across colorectal tumor models. Cancer Lett. 2026;641:218281.","journal-title":"Cancer Lett"},{"key":"1831_CR389","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020. https:\/\/doi.org\/10.1126\/science.aaw5473.","journal-title":"Science"},{"key":"1831_CR390","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105389","volume":"109","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Dong D, Yuan Y, Luo J, Liu XD, Chen LY, et al. Single cell atlas reveals multilayered metabolic heterogeneity across tumour types. EBioMedicine. 2024;109:105389.","journal-title":"EBioMedicine"},{"issue":"34","key":"1831_CR391","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202501435","volume":"37","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yao X, Lu Y, Ruan J, Yang Z, Wang C, et al. A PROTAC-based cuproptosis sensitizer in lung cancer therapy. Adv Mater. 2025;37(34):e2501435.","journal-title":"Adv Mater"},{"key":"1831_CR392","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2025.139625","volume":"706","author":"L Ma","year":"2026","unstructured":"Ma L, Zheng H, Xie W, Sun W, Yuan Q, Song K, et al. Dual-functional copper nanoplatform potentiates cuproptosis through p53 reactivation and metabolic reprogramming. J Colloid Interface Sci. 2026;706:139625.","journal-title":"J Colloid Interface Sci"},{"key":"1831_CR393","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16234054","author":"JS Modica-Napolitano","year":"2024","unstructured":"Modica-Napolitano JS, Murray M, Thibault J, Haley-Read JP, Nixdorf L, Shanahan B, et al. The in vitro cytotoxic effect of elesclomol on breast adenocarcinoma cells is enhanced by concurrent treatment with glycolytic inhibitors. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16234054.","journal-title":"Cancers (Basel)"},{"issue":"24","key":"1831_CR394","doi-asserted-by":"publisher","first-page":"21969","DOI":"10.1021\/acsnano.5c00012","volume":"19","author":"K Kim","year":"2025","unstructured":"Kim K, Lee J, Park OK, Lee H, Jang T, Kim J, et al. Enhanced cuproptosis via metabolic reprogramming using copper-delivering Co-N-C single-atom nanozyme. ACS Nano. 2025;19(24):21969\u201382.","journal-title":"ACS Nano"},{"issue":"1","key":"1831_CR395","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1021\/acsnano.5c15968","volume":"20","author":"H Liu","year":"2026","unstructured":"Liu H, Mao J, Wang M, Tian Q, Cai Q, An L. Copper-oxamate coordination polymers reverse cuproptosis resistance in nonsmall cell lung cancer via glycolysis reprogramming. ACS Nano. 2026;20(1):892\u2013904.","journal-title":"ACS Nano"},{"issue":"50","key":"1831_CR396","doi-asserted-by":"publisher","first-page":"34244","DOI":"10.1021\/acsnano.4c12123","volume":"18","author":"W Zhang","year":"2024","unstructured":"Zhang W, Chen Z, Xiong C, Yuan L, Hu JJ, Dai J, et al. A peptide-copper self-assembled nanoparticle for enhanced cuproptosis by metabolic reprogramming in tumor cells. ACS Nano. 2024;18(50):34244\u201356.","journal-title":"ACS Nano"},{"issue":"26","key":"1831_CR397","doi-asserted-by":"publisher","first-page":"e2504554","DOI":"10.1002\/smll.202504554","volume":"21","author":"A Chaudhary","year":"2025","unstructured":"Chaudhary A, Kumar A, Ankit A, Singh RG. Discovery of Cu(II)-dipyridophenazine complex for synergistic cuproptosis\/chemodynamic therapy via disrupting the tricarboxylic acid (TCA) cycle in metastatic TNBC. Small. 2025;21(26):e2504554.","journal-title":"Small"},{"issue":"18","key":"1831_CR398","doi-asserted-by":"publisher","first-page":"e202402397","DOI":"10.1002\/anie.202402397","volume":"63","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang M, Liu B, Chen H, Tan J, Meng Q, et al. Glutathione induced in situ synthesis of Cu single-atom nanozymes with anaerobic glycolysis metabolism interference for boosting cuproptosis. Angew Chem Int Ed Engl. 2024;63(18):e202402397.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"35","key":"1831_CR399","doi-asserted-by":"publisher","first-page":"e02154","DOI":"10.1002\/advs.202502154","volume":"12","author":"ZZ Li","year":"2025","unstructured":"Li ZZ, Liu Y, Zhou K, Cao LM, Wang GR, Wu J, et al. ORL@Cu-MOF boost cuproptosis and suppress fatty acid metabolism for cancer lymph node metastasis synergistic therapy. Adv Sci (Weinh). 2025;12(35):e02154.","journal-title":"Adv Sci (Weinh)"},{"key":"1831_CR400","doi-asserted-by":"publisher","first-page":"111563","DOI":"10.1016\/j.cellsig.2024.111563","volume":"127","author":"S Wu","year":"2025","unstructured":"Wu S, Weng J, Pan Y, Wen Z, Zeng J, Lou Y, et al. Disulfiram\/Cu targeting FOXO6 modulates sensitivity of hepatocellular carcinoma to lenvatinib via disrupt choline metabolic. Cell Signal. 2025;127:111563.","journal-title":"Cell Signal"},{"key":"1831_CR401","doi-asserted-by":"publisher","first-page":"123538","DOI":"10.1016\/j.biomaterials.2025.123538","volume":"325","author":"H Zhi","year":"2026","unstructured":"Zhi H, Yin W, Chen S, Zhang X, Yang Z, Man F, et al. Lactate metabolism regulating nanosystem synergizes cuproptosis and ferroptosis to enhance cancer immunotherapy. Biomaterials. 2026;325:123538.","journal-title":"Biomaterials"},{"issue":"5","key":"1831_CR402","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202406942","volume":"21","author":"Q Ma","year":"2025","unstructured":"Ma Q, Gao S, Li C, Yao J, Xie Y, Jiang C, et al. Cuproptosis and serine metabolism blockade triggered by copper-based Prussian blue nanomedicine for enhanced tumor therapy. Small. 2025;21(5):e2406942.","journal-title":"Small"},{"key":"1831_CR403","doi-asserted-by":"publisher","first-page":"102477","DOI":"10.1016\/j.mtbio.2025.102477","volume":"35","author":"H Shi","year":"2025","unstructured":"Shi H, Xie Z, Zhang J, Lu F, Luo H, Guo P, et al. Cu-doped dendritic biodegradable nanoplatforms for augmenting cuproptosis and tumor-starvation therapy through mitochondrial metabolic cascade modulation. Mater Today Bio. 2025;35:102477.","journal-title":"Mater Today Bio"},{"issue":"1","key":"1831_CR404","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1186\/s12951-024-02995-3","volume":"22","author":"Y Sun","year":"2024","unstructured":"Sun Y, Chen Y, Wu B, Li H, Wang Y, Wang X, et al. Synergistic SDT\/cuproptosis therapy for liver hepatocellular carcinoma: enhanced antitumor efficacy and specific mechanisms. J Nanobiotechnol. 2024;22(1):762.","journal-title":"J Nanobiotechnol"},{"issue":"23","key":"1831_CR405","doi-asserted-by":"publisher","first-page":"e2402516","DOI":"10.1002\/advs.202402516","volume":"11","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Niu X, Ding C, Lin Y, Fang W, Yan L, et al. Carrier-free self-assembly nano-sonosensitizers for sonodynamic-amplified cuproptosis-ferroptosis in glioblastoma therapy. Adv Sci (Weinh). 2024;11(23):e2402516.","journal-title":"Adv Sci (Weinh)"},{"key":"1831_CR406","doi-asserted-by":"publisher","first-page":"123874","DOI":"10.1016\/j.biomaterials.2025.123874","volume":"328","author":"Y Song","year":"2026","unstructured":"Song Y, Cheng W, Tian H, Huang Y, Huang C, Jia Y, et al. Nano-purpurin-Cu delivery via TPGS-induced macropinocytosis enables cuproptosis\/metabolic synergy to ablate cancer stemness and boost immunotherapy in colorectal cancer. Biomaterials. 2026;328:123874.","journal-title":"Biomaterials"},{"issue":"7","key":"1831_CR407","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1021\/acs.nanolett.3c00434","volume":"23","author":"K Chen","year":"2023","unstructured":"Chen K, Zhou A, Zhou X, Liu Y, Xu Y, Ning X. An intelligent cell-derived nanorobot bridges synergistic crosstalk between sonodynamic therapy and cuproptosis to promote cancer treatment. Nano Lett. 2023;23(7):3038\u201347.","journal-title":"Nano Lett"},{"issue":"12","key":"1831_CR408","doi-asserted-by":"publisher","first-page":"e202213922","DOI":"10.1002\/anie.202213922","volume":"62","author":"J Zhou","year":"2023","unstructured":"Zhou J, Yu Q, Song J, Li S, Li XL, Kang BK, et al. Photothermally triggered copper payload release for cuproptosis-promoted cancer synergistic therapy. Angew Chem Int Ed Engl. 2023;62(12):e202213922.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"8","key":"1831_CR409","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1021\/acs.biomac.5c01024","volume":"26","author":"S Xu","year":"2025","unstructured":"Xu S, Chen Z, Huang Y, Zhong Y, Chen W. Triphenylphosphine-chitosan functionalized MoS(2) nanosheets delivering elesclomol-Cu(II) complex for enhanced cuproptosis-mediated cancer therapy. Biomacromol. 2025;26(8):5438\u201349.","journal-title":"Biomacromol"},{"issue":"3","key":"1831_CR410","doi-asserted-by":"publisher","first-page":"e05739","DOI":"10.1002\/advs.202505739","volume":"13","author":"M Liu","year":"2026","unstructured":"Liu M, Zheng J, Yu M, Wang Q, Yuan Y, Shao N, et al. Stimuli-responsive CuFeTe(2) nanosheets for amplified cuproptosis\/ferroptosis in triple-negative breast cancer therapy. Adv Sci (Weinh). 2026;13(3):e05739.","journal-title":"Adv Sci (Weinh)"},{"key":"1831_CR411","doi-asserted-by":"publisher","first-page":"213604","DOI":"10.1016\/j.ccr.2020.213604","volume":"427","author":"J Du","year":"2021","unstructured":"Du J, Shi T, Long S, Chen P, Sun W, Fan J, et al. Enhanced photodynamic therapy for overcoming tumor hypoxia: from microenvironment regulation to photosensitizer innovation. Coord Chem Rev. 2021;427:213604.","journal-title":"Coord Chem Rev"},{"issue":"3","key":"1831_CR412","doi-asserted-by":"publisher","first-page":"e70599","DOI":"10.1002\/cam4.70599","volume":"14","author":"J Zhang","year":"2025","unstructured":"Zhang J, Zhang A, Guo Y, Miao G, Liang S, Wang J, et al. Nanoparticle-mediated cuproptosis and photodynamic synergistic strategy: a novel horizon for cancer therapy. Cancer Med. 2025;14(3):e70599.","journal-title":"Cancer Med"},{"issue":"20","key":"1831_CR413","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1039\/D5BM00954E","volume":"13","author":"YG Hu","year":"2025","unstructured":"Hu YG, Zhang F, Chen LL, Xu XY, Zhang PJ, Li Y, et al. Composite nano copper carrier combining cuproptosis and photodynamic therapy for spatiotemporal synergistic anti-tumor therapy. Biomater Sci. 2025;13(20):5705\u201316.","journal-title":"Biomater Sci"},{"issue":"10","key":"1831_CR414","doi-asserted-by":"publisher","first-page":"e2304407","DOI":"10.1002\/smll.202304407","volume":"20","author":"J Zheng","year":"2024","unstructured":"Zheng J, Ge H, Guo M, Zhang T, Hu Q, Yao Q, et al. Photoinduced cuproptosis with tumor-specific for metastasis-inhibited cancer therapy. Small. 2024;20(10):e2304407.","journal-title":"Small"},{"issue":"11","key":"1831_CR415","doi-asserted-by":"publisher","first-page":"10206","DOI":"10.1021\/acsnano.3c00326","volume":"17","author":"S Ning","year":"2023","unstructured":"Ning S, Lyu M, Zhu D, Lam JWY, Huang Q, Zhang T, et al. Type-I AIE photosensitizer loaded biomimetic system boosting cuproptosis to inhibit breast cancer metastasis and rechallenge. ACS Nano. 2023;17(11):10206\u201317.","journal-title":"ACS Nano"},{"issue":"9","key":"1831_CR416","doi-asserted-by":"publisher","first-page":"e2404612","DOI":"10.1002\/adhm.202404612","volume":"14","author":"Z Yu","year":"2025","unstructured":"Yu Z, Cao L, Shen Y, Chen J, Li H, Li C, et al. Inducing cuproptosis with copper ion-loaded aloe emodin self-assembled nanoparticles for enhanced tumor photodynamic immunotherapy. Adv Healthc Mater. 2025;14(9):e2404612.","journal-title":"Adv Healthc Mater"},{"issue":"Pt 1","key":"1831_CR417","doi-asserted-by":"publisher","first-page":"114281","DOI":"10.1016\/j.jconrel.2025.114281","volume":"388","author":"R Yang","year":"2025","unstructured":"Yang R, Deng F, Gao Z, Li X, Huangfu S, Tian Q, et al. Melanoma MHC-I-membrane-encapsulated Cu@ferrihydrite induces ferroptosis\/cuproptosis and systematic immunity against tumor. J Control Release. 2025;388(Pt 1):114281.","journal-title":"J Control Release"},{"key":"1831_CR418","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.actbio.2023.12.022","volume":"175","author":"W Liang","year":"2024","unstructured":"Liang W, Han C, Zhang D, Liu C, Zhu M, Xu F, et al. Copper-coordinated nanoassemblies based on photosensitizer-chemo prodrugs and checkpoint inhibitors for enhanced apoptosis-cuproptosis and immunotherapy. Acta Biomater. 2024;175:341\u201352.","journal-title":"Acta Biomater"},{"issue":"1","key":"1831_CR419","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S1470-2045(23)00524-7","volume":"25","author":"Y Fujiwara","year":"2024","unstructured":"Fujiwara Y, Horita N, Adib E, Zhou S, Nassar AH, Asad ZULA, et al. Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trials. Lancet Oncol. 2024;25(1):62\u201375.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1831_CR420","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12935-025-03688-z","volume":"25","author":"S Wang","year":"2025","unstructured":"Wang S, Xue X, Bai H, Qi J, Fei S, Miao B. Establishment and evaluation cuproptosis-related gene signature for predicting the prognosis and immunotherapy response of hepatocellular carcinoma. Cancer Cell Int. 2025;25(1):166.","journal-title":"Cancer Cell Int"},{"issue":"10","key":"1831_CR421","doi-asserted-by":"publisher","first-page":"e2216722120","DOI":"10.1073\/pnas.2216722120","volume":"120","author":"M Zulkifli","year":"2023","unstructured":"Zulkifli M, Spelbring AN, Zhang Y, Soma S, Chen S, Li L, et al. FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery. Proc Natl Acad Sci U S A. 2023;120(10):e2216722120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1831_CR422","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","volume":"187","author":"C Swanton","year":"2024","unstructured":"Swanton C, Bernard E, Abbosh C, Andr\u00e9 F, Auwerx J, Balmain A, et al. Embracing cancer complexity: hallmarks of systemic disease. Cell. 2024;187(7):1589\u2013616.","journal-title":"Cell"},{"issue":"13","key":"1831_CR423","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1111\/jcmm.16578","volume":"25","author":"T Xia","year":"2021","unstructured":"Xia T, Du WL, Chen XY, Zhang YN. Organoid models of the tumor microenvironment and their applications. J Cell Mol Med. 2021;25(13):5829\u201341.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1831_CR424","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s13046-024-03258-7","volume":"43","author":"G Blandino","year":"2024","unstructured":"Blandino G, Satchi-Fainaro R, Tinhofer I, Tonon G, Heilshorn SC, Kwon YJ, et al. Cancer organoids as reliable disease models to drive clinical development of novel therapies. J Exp Clin Cancer Res. 2024;43(1):334.","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"1831_CR425","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1021\/acs.analchem.4c05626","volume":"97","author":"M Schannor","year":"2025","unstructured":"Schannor M, Oelze M, Traub H, He Y, Schmidt R, Heidemann L, et al. Advancing biomarker research: in situ Cu isotope analysis in liver tumors by LA-MC-ICP-MS. Anal Chem. 2025;97(8):4425\u201332.","journal-title":"Anal Chem"},{"issue":"11","key":"1831_CR426","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/nmat4718","volume":"15","author":"KM Tsoi","year":"2016","unstructured":"Tsoi KM, MacParland SA, Ma XZ, Spetzler VN, Echeverri J, Ouyang B, et al. Mechanism of hard-nanomaterial clearance by the liver. Nat Mater. 2016;15(11):1212\u201321.","journal-title":"Nat Mater"},{"issue":"1","key":"1831_CR427","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12989-025-00633-w","volume":"22","author":"Y Chen","year":"2025","unstructured":"Chen Y, Nan Y, Xu L, Dai A, Orteg RMM, Ma M, et al. Polystyrene nanoplastics exposure induces cognitive impairment in mice via induction of oxidative stress and ERK\/MAPK-mediated neuronal cuproptosis. Part Fibre Toxicol. 2025;22(1):13.","journal-title":"Part Fibre Toxicol"},{"issue":"36","key":"1831_CR428","doi-asserted-by":"publisher","first-page":"e02783","DOI":"10.1002\/smll.202502783","volume":"21","author":"T Xie","year":"2025","unstructured":"Xie T, Shan Y, Topatana W, Yang T, Shen R, Li S, et al. Targeted intracellular copper reservoir enhances liver cancer immunotherapy. Small. 2025;21(36):e02783.","journal-title":"Small"},{"key":"1831_CR429","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-011472","author":"H Yang","year":"2025","unstructured":"Yang H, Deng B, Han X, Wang L, Zhao J, Zhao Y, et al. C5a\/C5aR pathway blocking promoted CuS-mediated cancer therapy effect by inhibiting cuproptosis resistance. J Immunother Cancer. 2025. https:\/\/doi.org\/10.1136\/jitc-2025-011472.","journal-title":"J Immunother Cancer"},{"key":"1831_CR430","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030512","author":"J Wang","year":"2024","unstructured":"Wang J, Li J, Liu J, Chan KY, Lee HS, Lin KN, et al. Interplay of ferroptosis and cuproptosis in cancer: dissecting metal-driven mechanisms for therapeutic potentials. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16030512.","journal-title":"Cancers (Basel)"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-026-01831-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01831-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01831-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:04:50Z","timestamp":1788278690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13045-026-01831-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":430,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1831"],"URL":"https:\/\/doi.org\/10.1186\/s13045-026-01831-5","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"1 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Generative AI and AI-assisted technologies were NOT used in the preparation of this work.","order":2,"name":"Ethics","label":"Declaration of Generative AI Use","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"73"}}